DE08020700T1 - Zusammensetzungen mit fluorosubstituierten Olefinen - Google Patents
Zusammensetzungen mit fluorosubstituierten Olefinen Download PDFInfo
- Publication number
- DE08020700T1 DE08020700T1 DE08020700T DE08020700T DE08020700T1 DE 08020700 T1 DE08020700 T1 DE 08020700T1 DE 08020700 T DE08020700 T DE 08020700T DE 08020700 T DE08020700 T DE 08020700T DE 08020700 T1 DE08020700 T1 DE 08020700T1
- Authority
- DE
- Germany
- Prior art keywords
- groups
- group
- compound
- carbon atoms
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims 5
- 150000001336 alkenes Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 89
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 44
- 125000000217 alkyl group Chemical group 0.000 claims abstract 35
- 125000003342 alkenyl group Chemical group 0.000 claims abstract 22
- 125000000304 alkynyl group Chemical group 0.000 claims abstract 21
- 150000004703 alkoxides Chemical group 0.000 claims abstract 20
- 125000003118 aryl group Chemical group 0.000 claims abstract 17
- 229910052736 halogen Inorganic materials 0.000 claims abstract 16
- -1 thicyano Chemical compound 0.000 claims abstract 16
- 150000002367 halogens Chemical class 0.000 claims abstract 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract 10
- 125000005843 halogen group Chemical group 0.000 claims abstract 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims abstract 9
- 125000001261 isocyanato group Chemical group *N=C=O 0.000 claims abstract 9
- 150000003573 thiols Chemical group 0.000 claims abstract 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 7
- 125000001651 cyanato group Chemical group [*]OC#N 0.000 claims abstract 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 6
- 125000001424 substituent group Chemical group 0.000 claims abstract 6
- 239000001257 hydrogen Substances 0.000 claims abstract 5
- 150000003568 thioethers Chemical class 0.000 claims abstract 5
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 4
- 125000000858 thiocyanato group Chemical group *SC#N 0.000 claims abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract 3
- 150000004679 hydroxides Chemical group 0.000 claims abstract 3
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 claims abstract 3
- 125000001810 isothiocyanato group Chemical group *N=C=S 0.000 claims abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052799 carbon Inorganic materials 0.000 claims abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims abstract 2
- LNQMAGOUQKHYNT-UHFFFAOYSA-N sulfanylidenemethylidenehydrazine Chemical compound NN=C=S LNQMAGOUQKHYNT-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 23
- 206010028980 Neoplasm Diseases 0.000 claims 13
- 201000011510 cancer Diseases 0.000 claims 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 6
- 230000030833 cell death Effects 0.000 claims 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 125000000547 substituted alkyl group Chemical group 0.000 claims 6
- 230000006907 apoptotic process Effects 0.000 claims 5
- 229910052801 chlorine Inorganic materials 0.000 claims 5
- 239000000460 chlorine Substances 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 239000002246 antineoplastic agent Substances 0.000 claims 4
- 229940127089 cytotoxic agent Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 claims 4
- 102000011727 Caspases Human genes 0.000 claims 3
- 108010076667 Caspases Proteins 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- 125000000732 arylene group Chemical group 0.000 claims 3
- 230000000973 chemotherapeutic effect Effects 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical group CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 claims 3
- 125000005549 heteroarylene group Chemical group 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 claims 3
- 239000003981 vehicle Substances 0.000 claims 3
- FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 claims 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 2
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 2
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 2
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 2
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- VWUXBMIQPBEWFH-WCCTWKNTSA-N Fulvestrant Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 claims 2
- 239000005517 L01XE01 - Imatinib Substances 0.000 claims 2
- 239000005411 L01XE02 - Gefitinib Substances 0.000 claims 2
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims 2
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 2
- 229930012538 Paclitaxel Natural products 0.000 claims 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 claims 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 229960000473 altretamine Drugs 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 229960003901 dacarbazine Drugs 0.000 claims 2
- 229960004679 doxorubicin Drugs 0.000 claims 2
- GTTBEUCJPZQMDZ-UHFFFAOYSA-N erlotinib hydrochloride Chemical compound [H+].[Cl-].C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 GTTBEUCJPZQMDZ-UHFFFAOYSA-N 0.000 claims 2
- 229960005420 etoposide Drugs 0.000 claims 2
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- 229960002258 fulvestrant Drugs 0.000 claims 2
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 claims 2
- UUVWYPNAQBNQJQ-UHFFFAOYSA-N hexamethylmelamine Chemical compound CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1 UUVWYPNAQBNQJQ-UHFFFAOYSA-N 0.000 claims 2
- 229960001101 ifosfamide Drugs 0.000 claims 2
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 claims 2
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 claims 2
- 229960001924 melphalan Drugs 0.000 claims 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 claims 2
- 230000011278 mitosis Effects 0.000 claims 2
- 229960001592 paclitaxel Drugs 0.000 claims 2
- 229960002340 pentostatin Drugs 0.000 claims 2
- FPVKHBSQESCIEP-JQCXWYLXSA-N pentostatin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC[C@H]2O)=C2N=C1 FPVKHBSQESCIEP-JQCXWYLXSA-N 0.000 claims 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 2
- WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- KTFMPDDJYRFWQE-DDWIOCJRSA-N (3r)-3-propanoyloxy-4-(trimethylazaniumyl)butanoate;hydrochloride Chemical compound [Cl-].CCC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C KTFMPDDJYRFWQE-DDWIOCJRSA-N 0.000 claims 1
- FPVKHBSQESCIEP-UHFFFAOYSA-N (8S)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol Natural products C1C(O)C(CO)OC1N1C(NC=NCC2O)=C2N=C1 FPVKHBSQESCIEP-UHFFFAOYSA-N 0.000 claims 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 claims 1
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 claims 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 claims 1
- GCKMFJBGXUYNAG-UHFFFAOYSA-N 17alpha-methyltestosterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C)(O)C1(C)CC2 GCKMFJBGXUYNAG-UHFFFAOYSA-N 0.000 claims 1
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 claims 1
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 claims 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 claims 1
- 125000005916 2-methylpentyl group Chemical group 0.000 claims 1
- NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 claims 1
- 125000005917 3-methylpentyl group Chemical group 0.000 claims 1
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 claims 1
- IDPUKCWIGUEADI-UHFFFAOYSA-N 5-[bis(2-chloroethyl)amino]uracil Chemical compound ClCCN(CCCl)C1=CNC(=O)NC1=O IDPUKCWIGUEADI-UHFFFAOYSA-N 0.000 claims 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 claims 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 claims 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 claims 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N Arsenious Acid Chemical compound O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 claims 1
- 108010024976 Asparaginase Proteins 0.000 claims 1
- OLCWFLWEHWLBTO-HSZRJFAPSA-N BMS-214662 Chemical compound C=1C=CSC=1S(=O)(=O)N([C@@H](C1)CC=2C=CC=CC=2)CC2=CC(C#N)=CC=C2N1CC1=CN=CN1 OLCWFLWEHWLBTO-HSZRJFAPSA-N 0.000 claims 1
- 108010006654 Bleomycin Proteins 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 claims 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 claims 1
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 1
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 claims 1
- JWBOIMRXGHLCPP-UHFFFAOYSA-N Chloditan Chemical compound C=1C=CC=C(Cl)C=1C(C(Cl)Cl)C1=CC=C(Cl)C=C1 JWBOIMRXGHLCPP-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 230000005778 DNA damage Effects 0.000 claims 1
- 231100000277 DNA damage Toxicity 0.000 claims 1
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 claims 1
- 108010069236 Goserelin Proteins 0.000 claims 1
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 claims 1
- XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- 239000005551 L01XE03 - Erlotinib Substances 0.000 claims 1
- 108010000817 Leuprolide Proteins 0.000 claims 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 claims 1
- GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 claims 1
- GZQSEHHENRVCNH-UHFFFAOYSA-N N#COS([N+](=O)[O-])(C#N)([N+]#[C-])=C=NN(SC#N)N=C=O Chemical compound N#COS([N+](=O)[O-])(C#N)([N+]#[C-])=C=NN(SC#N)N=C=O GZQSEHHENRVCNH-UHFFFAOYSA-N 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 claims 1
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 claims 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims 1
- 229940009456 adriamycin Drugs 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000006294 amino alkylene group Chemical group 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- ROBVIMPUHSLWNV-UHFFFAOYSA-N aminoglutethimide Chemical compound C=1C=C(N)C=CC=1C1(CC)CCC(=O)NC1=O ROBVIMPUHSLWNV-UHFFFAOYSA-N 0.000 claims 1
- 229960003437 aminoglutethimide Drugs 0.000 claims 1
- 229960001220 amsacrine Drugs 0.000 claims 1
- XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 claims 1
- 229960002932 anastrozole Drugs 0.000 claims 1
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 claims 1
- 229940120638 avastin Drugs 0.000 claims 1
- 229960001561 bleomycin Drugs 0.000 claims 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims 1
- 229960002092 busulfan Drugs 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229940112129 campath Drugs 0.000 claims 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims 1
- 229940127093 camptothecin Drugs 0.000 claims 1
- 229960004117 capecitabine Drugs 0.000 claims 1
- 229960004562 carboplatin Drugs 0.000 claims 1
- 190000008236 carboplatin Chemical compound 0.000 claims 1
- 229960005243 carmustine Drugs 0.000 claims 1
- 201000007455 central nervous system cancer Diseases 0.000 claims 1
- 229960005395 cetuximab Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 claims 1
- 229960004630 chlorambucil Drugs 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- 229960004397 cyclophosphamide Drugs 0.000 claims 1
- 229960000684 cytarabine Drugs 0.000 claims 1
- 229960000975 daunorubicin Drugs 0.000 claims 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 claims 1
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 claims 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 claims 1
- 229960000452 diethylstilbestrol Drugs 0.000 claims 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 claims 1
- 229960003668 docetaxel Drugs 0.000 claims 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 1
- 229960001904 epirubicin Drugs 0.000 claims 1
- 229930013356 epothilone Natural products 0.000 claims 1
- HESCAJZNRMSMJG-KKQRBIROSA-N epothilone A Chemical class C/C([C@@H]1C[C@@H]2O[C@@H]2CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 HESCAJZNRMSMJG-KKQRBIROSA-N 0.000 claims 1
- 229960005073 erlotinib hydrochloride Drugs 0.000 claims 1
- 229960001842 estramustine Drugs 0.000 claims 1
- FRPJXPJMRWBBIH-RBRWEJTLSA-N estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 claims 1
- 229960000255 exemestane Drugs 0.000 claims 1
- ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 claims 1
- 229960000961 floxuridine Drugs 0.000 claims 1
- 229960005304 fludarabine phosphate Drugs 0.000 claims 1
- GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 claims 1
- YLRFCQOZQXIBAB-RBZZARIASA-N fluoxymesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)C[C@@H]2O YLRFCQOZQXIBAB-RBZZARIASA-N 0.000 claims 1
- 229960001751 fluoxymesterone Drugs 0.000 claims 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 claims 1
- 229960002074 flutamide Drugs 0.000 claims 1
- 229960002584 gefitinib Drugs 0.000 claims 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
- 229960005277 gemcitabine Drugs 0.000 claims 1
- 229940080856 gleevec Drugs 0.000 claims 1
- 229960002913 goserelin Drugs 0.000 claims 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 1
- 229940022353 herceptin Drugs 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229960002899 hydroxyprogesterone Drugs 0.000 claims 1
- 229960001001 ibritumomab tiuxetan Drugs 0.000 claims 1
- 229960000908 idarubicin Drugs 0.000 claims 1
- 229960002411 imatinib Drugs 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 229940084651 iressa Drugs 0.000 claims 1
- 229960004768 irinotecan Drugs 0.000 claims 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 229960003881 letrozole Drugs 0.000 claims 1
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 229960001614 levamisole Drugs 0.000 claims 1
- 229960002247 lomustine Drugs 0.000 claims 1
- DHMTURDWPRKSOA-RUZDIDTESA-N lonafarnib Chemical compound C1CN(C(=O)N)CCC1CC(=O)N1CCC([C@@H]2C3=C(Br)C=C(Cl)C=C3CCC3=CC(Br)=CN=C32)CC1 DHMTURDWPRKSOA-RUZDIDTESA-N 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 229960004961 mechlorethamine Drugs 0.000 claims 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 claims 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 claims 1
- 229960002985 medroxyprogesterone acetate Drugs 0.000 claims 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 claims 1
- 229960004296 megestrol acetate Drugs 0.000 claims 1
- 229960001428 mercaptopurine Drugs 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229960004584 methylprednisolone Drugs 0.000 claims 1
- 229960001566 methyltestosterone Drugs 0.000 claims 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 claims 1
- 229960004857 mitomycin Drugs 0.000 claims 1
- 229960000350 mitotane Drugs 0.000 claims 1
- 229960001156 mitoxantrone Drugs 0.000 claims 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- NJBFOOCLYDNZJN-UHFFFAOYSA-N pipobroman Chemical compound BrCCC(=O)N1CCN(C(=O)CCBr)CC1 NJBFOOCLYDNZJN-UHFFFAOYSA-N 0.000 claims 1
- 229960000952 pipobroman Drugs 0.000 claims 1
- 229960003171 plicamycin Drugs 0.000 claims 1
- 229960005205 prednisolone Drugs 0.000 claims 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 claims 1
- 229960004618 prednisone Drugs 0.000 claims 1
- 229960000624 procarbazine Drugs 0.000 claims 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 claims 1
- 125000005412 pyrazyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 229960004641 rituximab Drugs 0.000 claims 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 229960001052 streptozocin Drugs 0.000 claims 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 229960001603 tamoxifen Drugs 0.000 claims 1
- 229940120982 tarceva Drugs 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 229940063683 taxotere Drugs 0.000 claims 1
- 229960004964 temozolomide Drugs 0.000 claims 1
- 229960005353 testolactone Drugs 0.000 claims 1
- BPEWUONYVDABNZ-DZBHQSCQSA-N testolactone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(OC(=O)CC4)[C@@H]4[C@@H]3CCC2=C1 BPEWUONYVDABNZ-DZBHQSCQSA-N 0.000 claims 1
- 229960003604 testosterone Drugs 0.000 claims 1
- 229960001196 thiotepa Drugs 0.000 claims 1
- 229960003087 tioguanine Drugs 0.000 claims 1
- PLHJCIYEEKOWNM-HHHXNRCGSA-N tipifarnib Chemical compound CN1C=NC=C1[C@](N)(C=1C=C2C(C=3C=C(Cl)C=CC=3)=CC(=O)N(C)C2=CC=1)C1=CC=C(Cl)C=C1 PLHJCIYEEKOWNM-HHHXNRCGSA-N 0.000 claims 1
- 229960000303 topotecan Drugs 0.000 claims 1
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 claims 1
- XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 claims 1
- 229960005026 toremifene Drugs 0.000 claims 1
- 229960005267 tositumomab Drugs 0.000 claims 1
- 229950001353 tretamine Drugs 0.000 claims 1
- IUCJMVBFZDHPDX-UHFFFAOYSA-N tretamine Chemical compound C1CN1C1=NC(N2CC2)=NC(N2CC2)=N1 IUCJMVBFZDHPDX-UHFFFAOYSA-N 0.000 claims 1
- 229960005294 triamcinolone Drugs 0.000 claims 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims 1
- 229940086984 trisenox Drugs 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 229960001055 uracil mustard Drugs 0.000 claims 1
- 229960003048 vinblastine Drugs 0.000 claims 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims 1
- 229960004528 vincristine Drugs 0.000 claims 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 1
- 229960004355 vindesine Drugs 0.000 claims 1
- UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 claims 1
- GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 claims 1
- 229960002066 vinorelbine Drugs 0.000 claims 1
- 229940053867 xeloda Drugs 0.000 claims 1
- 0 C*OP(C(c1ccccc1)(c1ccccc1)c1ccccc1)(OI)=O Chemical compound C*OP(C(c1ccccc1)(c1ccccc1)c1ccccc1)(OI)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K5/00—Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants; Materials for the production of heat or cold by chemical reactions other than by combustion
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23G—CLEANING OR DE-GREASING OF METALLIC MATERIAL BY CHEMICAL METHODS OTHER THAN ELECTROLYSIS
- C23G5/00—Cleaning or de-greasing metallic material by other methods; Apparatus for cleaning or de-greasing metallic material with organic solvents
- C23G5/02—Cleaning or de-greasing metallic material by other methods; Apparatus for cleaning or de-greasing metallic material with organic solvents using organic solvents
- C23G5/028—Cleaning or de-greasing metallic material by other methods; Apparatus for cleaning or de-greasing metallic material with organic solvents using organic solvents containing halogenated hydrocarbons
- C23G5/02803—Cleaning or de-greasing metallic material by other methods; Apparatus for cleaning or de-greasing metallic material with organic solvents using organic solvents containing halogenated hydrocarbons containing fluorine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N29/00—Biocides, pest repellants or attractants, or plant growth regulators containing halogenated hydrocarbons
- A01N29/02—Acyclic compounds or compounds containing halogen attached to an aliphatic side-chain of a cycloaliphatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D1/00—Fire-extinguishing compositions; Use of chemical substances in extinguishing fires
- A62D1/0092—Gaseous extinguishing substances, e.g. liquefied gases, carbon dioxide snow
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C19/00—Acyclic saturated compounds containing halogen atoms
- C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C21/00—Acyclic unsaturated compounds containing halogen atoms
- C07C21/02—Acyclic unsaturated compounds containing halogen atoms containing carbon-to-carbon double bonds
- C07C21/18—Acyclic unsaturated compounds containing halogen atoms containing carbon-to-carbon double bonds containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
- C08J9/143—Halogen containing compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
- C08J9/143—Halogen containing compounds
- C08J9/144—Halogen containing compounds containing carbon, halogen and hydrogen only
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
- C08J9/143—Halogen containing compounds
- C08J9/144—Halogen containing compounds containing carbon, halogen and hydrogen only
- C08J9/146—Halogen containing compounds containing carbon, halogen and hydrogen only only fluorine as halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K21/00—Fireproofing materials
- C09K21/06—Organic materials
- C09K21/08—Organic materials containing halogen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K5/00—Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants; Materials for the production of heat or cold by chemical reactions other than by combustion
- C09K5/02—Materials undergoing a change of physical state when used
- C09K5/04—Materials undergoing a change of physical state when used the change of state being from liquid to vapour or vice versa
- C09K5/041—Materials undergoing a change of physical state when used the change of state being from liquid to vapour or vice versa for compression-type refrigeration systems
- C09K5/044—Materials undergoing a change of physical state when used the change of state being from liquid to vapour or vice versa for compression-type refrigeration systems comprising halogenated compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K5/00—Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants; Materials for the production of heat or cold by chemical reactions other than by combustion
- C09K5/02—Materials undergoing a change of physical state when used
- C09K5/04—Materials undergoing a change of physical state when used the change of state being from liquid to vapour or vice versa
- C09K5/041—Materials undergoing a change of physical state when used the change of state being from liquid to vapour or vice versa for compression-type refrigeration systems
- C09K5/044—Materials undergoing a change of physical state when used the change of state being from liquid to vapour or vice versa for compression-type refrigeration systems comprising halogenated compounds
- C09K5/045—Materials undergoing a change of physical state when used the change of state being from liquid to vapour or vice versa for compression-type refrigeration systems comprising halogenated compounds containing only fluorine as halogen
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M131/00—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing halogen
- C10M131/02—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing halogen containing carbon, hydrogen and halogen only
- C10M131/04—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing halogen containing carbon, hydrogen and halogen only aliphatic
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M141/00—Lubricating compositions characterised by the additive being a mixture of two or more compounds covered by more than one of the main groups C10M125/00 - C10M139/00, each of these compounds being essential
- C10M141/04—Lubricating compositions characterised by the additive being a mixture of two or more compounds covered by more than one of the main groups C10M125/00 - C10M139/00, each of these compounds being essential at least one of them being an organic halogen-containing compound
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M171/00—Lubricating compositions characterised by purely physical criteria, e.g. containing as base-material, thickener or additive, ingredients which are characterised exclusively by their numerically specified physical properties, i.e. containing ingredients which are physically well-defined but for which the chemical nature is either unspecified or only very vaguely indicated
- C10M171/008—Lubricant compositions compatible with refrigerants
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/24—Organic compounds containing halogen
- C11D3/245—Organic compounds containing halogen containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/50—Solvents
- C11D7/5004—Organic solvents
- C11D7/5018—Halogenated solvents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/50—Solvents
- C11D7/5036—Azeotropic mixtures containing halogenated solvents
- C11D7/504—Azeotropic mixtures containing halogenated solvents all solvents being halogenated hydrocarbons
- C11D7/505—Mixtures of (hydro)fluorocarbons
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
- F25B1/00—Compression machines, plants or systems with non-reversible cycle
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
- F25B39/00—Evaporators; Condensers
- F25B39/02—Evaporators
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
- F25B39/00—Evaporators; Condensers
- F25B39/04—Condensers
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
- F25B41/00—Fluid-circulation arrangements
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2203/00—Foams characterized by the expanding agent
- C08J2203/16—Unsaturated hydrocarbons
- C08J2203/162—Halogenated unsaturated hydrocarbons, e.g. H2C=CF2
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2205/00—Foams characterised by their properties
- C08J2205/04—Foams characterised by their properties characterised by the foam pores
- C08J2205/052—Closed cells, i.e. more than 50% of the pores are closed
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2207/00—Foams characterised by their intended use
- C08J2207/04—Aerosol, e.g. polyurethane foam spray
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
- C08J2375/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2205/00—Aspects relating to compounds used in compression type refrigeration systems
- C09K2205/10—Components
- C09K2205/12—Hydrocarbons
- C09K2205/126—Unsaturated fluorinated hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2205/00—Aspects relating to compounds used in compression type refrigeration systems
- C09K2205/22—All components of a mixture being fluoro compounds
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2203/00—Organic non-macromolecular hydrocarbon compounds and hydrocarbon fractions as ingredients in lubricant compositions
- C10M2203/06—Well-defined aromatic compounds
- C10M2203/065—Well-defined aromatic compounds used as base material
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2203/00—Organic non-macromolecular hydrocarbon compounds and hydrocarbon fractions as ingredients in lubricant compositions
- C10M2203/10—Petroleum or coal fractions, e.g. tars, solvents, bitumen
- C10M2203/1006—Petroleum or coal fractions, e.g. tars, solvents, bitumen used as base material
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2205/00—Organic macromolecular hydrocarbon compounds or fractions, whether or not modified by oxidation as ingredients in lubricant compositions
- C10M2205/02—Organic macromolecular hydrocarbon compounds or fractions, whether or not modified by oxidation as ingredients in lubricant compositions containing acyclic monomers
- C10M2205/0206—Organic macromolecular hydrocarbon compounds or fractions, whether or not modified by oxidation as ingredients in lubricant compositions containing acyclic monomers used as base material
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2207/00—Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
- C10M2207/28—Esters
- C10M2207/2805—Esters used as base material
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2209/00—Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
- C10M2209/10—Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C10M2209/103—Polyethers, i.e. containing di- or higher polyoxyalkylene groups
- C10M2209/1033—Polyethers, i.e. containing di- or higher polyoxyalkylene groups used as base material
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
- C10N2020/00—Specified physical or chemical properties or characteristics, i.e. function, of component of lubricating compositions
- C10N2020/09—Characteristics associated with water
- C10N2020/097—Refrigerants
- C10N2020/101—Containing Hydrofluorocarbons
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
- C10N2040/00—Specified use or application for which the lubricating composition is intended
- C10N2040/30—Refrigerators lubricants or compressors lubricants
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/28—Organic compounds containing halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Mechanical Engineering (AREA)
- Wood Science & Technology (AREA)
- Combustion & Propulsion (AREA)
- General Engineering & Computer Science (AREA)
- Metallurgy (AREA)
- General Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Agronomy & Crop Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Dentistry (AREA)
- Veterinary Medicine (AREA)
- Environmental Sciences (AREA)
- Business, Economics & Management (AREA)
- Emergency Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Lubricants (AREA)
- Detergent Compositions (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fire-Extinguishing Compositions (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
Verbindung, die die Formel FX1: Formel FX1 aufweist, wobei:
die Arylringe A, B und C unabhängig voneinander aus der Gruppe ausgewählt sind bestehend aus Phenylringen oder sechsgliedrigen aromatischen Ringen, wobei ein oder zwei Kohlenstoffatome durch Stickstoffe ersetzt, sind und die wahlweise an einem oder mehreren Ringkohlenstoff(en) substituiert sind;
XA, XB, XC ein oder mehrere Wasserstoff(e) oder Nichtwasserstoffringsubstituenten darstellt, die unabhängig aus der Gruppe ausgewählt sind bestehend aus Halogenen, Hydroxiden, Alkyl-, Alkenyl-, Alkynyl-, Alkoxid-, Thiol-, Thiolakoxid-, Ether-, Thioether-, Nitro-, Cyano-, Isocyano-, Cyanato-, Isocyanato-, Thicyano-, Isothiocyano-, Amin-, (-N(R'2)-, R'-CO-, R'O-CO-, (R')2N-CO-, (R')-COO-, (R')2N-COO-, (R')2N-CONR'-, R'SO2-, R'2NSO2-Gruppen, wobei Kohlenstoffatome dieser Substituentengruppen wahlweise durch ein oder mehrere Halogen(e), Hydroxid(e), Thiol(e), Nitrogruppe(n), Cyanogruppe(n), Isocyanogruppe(n), Cyanatogruppe(n), Isocyanatogruppe(n), Thiocyanatogruppe(n) oder Isothiocyanogruppe(n) substituiert sind, wobei R' unabhängig von anderen R' im Molekül unter H, Alkyl, Alkenyl, Alkynyl, Heterocyclen, Aryl, Heteroaryl ausgewählt sind, die alle wiederum wahlweise durch ein oder mehrere Halogen(e), Hydroxid(e), Alkyl-, Alkenyl-Alkynyl-, Alkoxid-, Thiol-, Thioalkoxid-Ether-,...
die Arylringe A, B und C unabhängig voneinander aus der Gruppe ausgewählt sind bestehend aus Phenylringen oder sechsgliedrigen aromatischen Ringen, wobei ein oder zwei Kohlenstoffatome durch Stickstoffe ersetzt, sind und die wahlweise an einem oder mehreren Ringkohlenstoff(en) substituiert sind;
XA, XB, XC ein oder mehrere Wasserstoff(e) oder Nichtwasserstoffringsubstituenten darstellt, die unabhängig aus der Gruppe ausgewählt sind bestehend aus Halogenen, Hydroxiden, Alkyl-, Alkenyl-, Alkynyl-, Alkoxid-, Thiol-, Thiolakoxid-, Ether-, Thioether-, Nitro-, Cyano-, Isocyano-, Cyanato-, Isocyanato-, Thicyano-, Isothiocyano-, Amin-, (-N(R'2)-, R'-CO-, R'O-CO-, (R')2N-CO-, (R')-COO-, (R')2N-COO-, (R')2N-CONR'-, R'SO2-, R'2NSO2-Gruppen, wobei Kohlenstoffatome dieser Substituentengruppen wahlweise durch ein oder mehrere Halogen(e), Hydroxid(e), Thiol(e), Nitrogruppe(n), Cyanogruppe(n), Isocyanogruppe(n), Cyanatogruppe(n), Isocyanatogruppe(n), Thiocyanatogruppe(n) oder Isothiocyanogruppe(n) substituiert sind, wobei R' unabhängig von anderen R' im Molekül unter H, Alkyl, Alkenyl, Alkynyl, Heterocyclen, Aryl, Heteroaryl ausgewählt sind, die alle wiederum wahlweise durch ein oder mehrere Halogen(e), Hydroxid(e), Alkyl-, Alkenyl-Alkynyl-, Alkoxid-, Thiol-, Thioalkoxid-Ether-,...
Claims (92)
- Verbindung, die die Formel FX1: Formel FX1 aufweist, wobei: die Arylringe A, B und C unabhängig voneinander aus der Gruppe ausgewählt sind bestehend aus Phenylringen oder sechsgliedrigen aromatischen Ringen, wobei ein oder zwei Kohlenstoffatome durch Stickstoffe ersetzt, sind und die wahlweise an einem oder mehreren Ringkohlenstoff(en) substituiert sind; XA, XB, XC ein oder mehrere Wasserstoff(e) oder Nichtwasserstoffringsubstituenten darstellt, die unabhängig aus der Gruppe ausgewählt sind bestehend aus Halogenen, Hydroxiden, Alkyl-, Alkenyl-, Alkynyl-, Alkoxid-, Thiol-, Thiolakoxid-, Ether-, Thioether-, Nitro-, Cyano-, Isocyano-, Cyanato-, Isocyanato-, Thicyano-, Isothiocyano-, Amin-, (-N(R'2)-, R'-CO-, R'O-CO-, (R')2N-CO-, (R')-COO-, (R')2N-COO-, (R')2N-CONR'-, R'SO2-, R'2NSO2-Gruppen, wobei Kohlenstoffatome dieser Substituentengruppen wahlweise durch ein oder mehrere Halogen(e), Hydroxid(e), Thiol(e), Nitrogruppe(n), Cyanogruppe(n), Isocyanogruppe(n), Cyanatogruppe(n), Isocyanatogruppe(n), Thiocyanatogruppe(n) oder Isothiocyanogruppe(n) substituiert sind, wobei R' unabhängig von anderen R' im Molekül unter H, Alkyl, Alkenyl, Alkynyl, Heterocyclen, Aryl, Heteroaryl ausgewählt sind, die alle wiederum wahlweise durch ein oder mehrere Halogen(e), Hydroxid(e), Alkyl-, Alkenyl-Alkynyl-, Alkoxid-, Thiol-, Thioalkoxid-Ether-, Thioether-, Nitro-, Cyano-, Isocyano-, Cyanato-, Isocyanato-, Thiocyano-, Isothiocyano-, Amin-, (-N(R'2)-, R''-CO-, R''O-CO-, (R'')2N-CO-, (R'')-COO-, (R'')2N-COO-, (R'')2N-CONR''-, R''SO2-, R''2NSO2-Gruppen substituiert sind, wobei R" unabhängig von anderen R" in dem Molekül aus der Gruppe ausgewählt sind bestehend aus Wasserstoff-, Alkyl-, Alkenyl-, Alkynyl-, Heterocyclus-, Aryl- oder Heteroarylgruppen, die wahlweise durch ein oder mehrere Halogen(e), Alkyl(e), Alkenyl(e), Aryl(e), Hydroxid(e), Thiol(e), Nitrogruppe(n), Cyanogruppe(n), Isocyanogruppe(n), Cyanatogruppe(n), Isocyanatogruppe(n), Thiocyanatogruppe(n) oder Isothiocyanogruppe(n) substituiert sind; und wobei die XA-, XB-, XC-Substitution wahlweise einen Verknüpfungsanteil zwischen zwei der Aryl-A-, -B- oder -C-Ringe umfasst, wobei der Verknüpfungsanteil unter -O-, -S-, -NB- oder -CR2'''- ausgewählt ist, wobei jedes R''' unabhängig von irgendeinem anderen R''' aus der Gruppe ausgewählt ist bestehend aus H oder Alkylgruppen, die 1-6 Kohlenstoffatome aufweisen; OR2 wahlweise durch Y ersetzt ist, das ein Halogen, bevorzugt Chlorid oder Fluorid ist; R1 und R2 unabhängig voneinander aus der Gruppe ausgewählt sind bestehend aus Alkyl-, Alkenyl-, Alkynyl-, Ether-, Thioether-, Heterocyclus-, Aryl- oder Heteroarylgruppen, die wahlweise durch ein oder mehrere Halogen(e), Hydroxid(e), Alkyl-, Alkenyl-, Alkynyl-, Alkoxid-, Thiol-, Thioalkoxid-, Ether-, Thioether-, Amin-, (-N(R')2)-, Nitro-, Cyano-, Isocyano-, Cyanato-, Isocyanato-, Thiocyano-, Isothiocyano-, R'-CO-, R'O-CO-, (R')2N-CO-, (R')-COO-, (R')2N-COO-, (R')2N-CONR'-, R'SO2- oder R'2NSO2-Gruppen substituiert sind, wobei R' die obige Definition aufweist und wobei R1 und R2 zusammen eine wahlweise substituierte (biradikalische) Alkylen- oder Alkenylengruppe bilden können, die 2 oder mehr Kohlenstoffatome aufweist, die zwischen den beiden Sauerstoffen in der Formel gebunden sind, die wiederum an Phosphor gebunden sind; jedes R unabhängig von anderen R im Molekül aus der Gruppe ausgewählt ist bestehend aus Wasserstoff, Hydroxid, Halogen, Alkyl, Alkoxid, wobei Kohlenstoffatome dieser Substituentengruppen wahlweise durch eine oder mehrere Halogene, Hydroxide, Thiole, Nitrogruppen, Cyanogruppen, Isocyanogruppen, Cyanatogruppen, Isocyanatogruppen, Thiocyanatogruppen oder Isothiocyanogruppen substituiert sind; und n 0, 1, 2, 3, 4, 5 oder 6 beträgt.
- Verbindung nach Anspruch 1, wobei OR2 nicht Y ist, mit der Ausnahme, dass beide von R1 und R2 nicht Alkylgruppen sein können.
- Verbindung nach Anspruch 1, wobei OR2 nicht Y ist, mit der Ausnahme, dass beide von R1 und R2 nicht Methyl-, Ethyl-, Isopropyl- oder Neopentylgruppen sein können.
- Verbindung nach Anspruch 1, wobei beide von R1 und R2 nicht Alkylgruppen sein können.
- Verbindung nach Anspruch 1, wobei die A-, B- und C-Ringe Phenylringe oder substituierte Phenylringe sind, die eine oder mehrere Hydroxylgruppen, Halogenatome, kleine Alkylgruppen (die 1-6 Kohlenstoffatome, bevorzugt 1-3 Kohlenstoffatome aufweisen) oder kleine Alkoxidgruppen (die 1-6 Kohlenstoffatome, bevorzugt 1-3 Kohlenstoffatome aufweisen) tragen.
- Verbindung nach Anspruch 1, wobei die A-, B- und C-Ringe Pyridylringe sind, die wahlweise eine oder mehrere Hydroxylgruppen, Halogenatome, kleine Alkylgruppen (die 1, 2 oder 3 Kohlenstoffatome aufweisen) oder kleine Alkoxidgruppen (die 1, 2 oder 3 Kohlenstoffatome aufweisen) an Ringkohlenstoffatomen tragen.
- Verbindung nach Anspruch 1, wobei die A-, B- und C-Ringe Pyrimidylringe sind, die wahlweise eine oder mehrere Hydroxylgruppen, Halogenatome, kleine Alkylgruppen (die 1, 2 oder 3 Kohlenstoffatome aufweisen) oder kleine Alkoxidgruppen (die 1, 2 oder 3 Kohlenstoffatome aufweisen) an Ringkohlenstoffatomen tragen.
- Verbindung nach Anspruch 1, wobei die A-, B- und C-Ringe Pyridazylringe sind, die wahlweise eine oder mehrere Hydroxylgruppen, Halogenatome, kleine Alkylgruppen (die 1, 2 oder 3 Kohlenstoffatome aufweisen) oder kleine Alkoxidgruppen (die 1, 2 oder 3 Kohlenstoffatome aufweisen) an Ringkohlenstoffatomen tragen.
- Verbindung nach Anspruch 1, wobei die A-, B- und C-Ringe Pyrazylringe sind, die wahlweise eine oder mehrere Hydroxylgruppen, Halogenatome, kleine Alkylgruppen (die 1, 2 oder 3 Kohlenstoffatome aufweisen) oder kleine Alkoxidgruppen (die 1, 2 oder 3 Kohlenstoffatome aufweisen) an Ringkohlenstoffatomen tragen.
- Verbindung nach Anspruch 1, wobei eines oder mehrere von XA, XB oder XC Halogenatome, Hydroxidgruppen, kleine Alkylgruppen oder kleine Alkoxidgruppen ist/sind.
- Verbindung nach Anspruch 1, wobei eines von XA, XB oder XC ein Halogenatom, eine Hydroxylgruppe, eine kleine Alkylgruppe oder eine kleine Alkoxidgruppe ist.
- Verbindung nach Anspruch 1, wobei XA, XB oder XC einen oder mehrere Nichtwasserstoffsubstituent(en) in den meta- und/oder para-Stellungen an den A-, B- oder C-Ringen darstellt.
- Verbindung nach Anspruch 1, wobei jedes von XA, XB und/oder XC einen einzigen Nichtwasserstoffsubstituenten an einem Ring darstellt.
- Verbindung nach Anspruch 1, wobei jedes von XA, XB und/oder XC einen einzigen Halogen-, Hydroxid-, kleinen Alkyl- oder kleinen Alkoxidsubstituenten an einem Ring darstellt.
- Verbindung nach Anspruch 1, wobei jedes von XA, XB und/oder XC einen einzigen Substituenten in para-Ringstellung darstellt und insbesondere einen einzigen Halogen-, Hydroxid-, kleinen Alkyl- oder kleinen Alkoxidsubstituenten in einer meta-Stellung an dem Ring darstellt.
- Verbindung nach Anspruch 1, wobei jedes von XA, XB und/oder XC einen einzigen Substituenten in meta-Ringstellung darstellt und insbesondere einen einzigen Halogen-, Hydroxid-, kleinen Alkyl- oder kleinen Alkoxidsubstituenten in einer meta-Stellung an dem Ring darstellt.
- Verbindung nach Anspruch 1, wobei n 0 beträgt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei eines oder zwei von XA, XB und/oder XC eine einzige OH-Gruppe in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei eines oder zwei von XA, XB und/oder XC eine einzige Alkoxidgruppe in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei eines oder zwei von XA, XB und/oder XC eine einzige Methoxid- oder Ethoxid-Gruppe in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei n 0 beträgt, R1 und R2 beide unsubstituierte Alkylgruppen sind und eines oder zwei von XA, XB und/oder XC eine einzige OH-Gruppe in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei n 0 beträgt, R1 und R2 beide unsubstituierte Alkylgruppen sind und eines oder zwei von XA, XB und/oder XC eine einzige Alkoxidgruppe in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei n 0 beträgt, R1 und R2 beide unsubstituierte Alkylgruppen sind und eines oder zwei von XA, XB und/oder XC eine einzige Methoxid- oder Ethoxidgruppe in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei n 0 beträgt, R1 und R2 beide Methyl-, Ethyl- oder Propylgruppen sind und eines oder zwei von XA, XB und/oder XC eine einzige OH-Gruppe in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei n 0 beträgt, R1 und R2 beide Methyl-, Ethyl- oder Propylgruppen sind und eines oder zwei von XA, XB und/oder XC eine einzige Alkoxidgruppe in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei n 0 beträgt, R1 und R2 beide Methyl-, Ethyl- oder Propylgruppen sind und eines oder zwei von XA, XB und/oder XC ein einziges Methoxid oder Ethoxid in der para-Stellung am Ring darstellt.
- Verbindung nach Anspruch 1, ausschließlich einer oder mehrerer Strukturen, wobei n 0 beträgt, R1 und R2 beide unsubstituierte Alkylgruppen sind und jedes von XA, XB und/oder XC Wasserstoffe sind.
- Verbindung nach Anspruch 1, wobei OR2 nicht durch ein Halogen ersetzt ist.
- Verbindung nach Anspruch 1, wobei R1 und R2 Gruppen sind, bei denen es sich nicht um Ethyl- oder Methylgruppen handelt.
- Verbindung nach Anspruch 1, wobei R1 und R2 Gruppen sind, bei denen es sich nicht um Alkylgruppen handelt, die 1-3 Kohlenstoffatome aufweisen.
- Verbindung nach Anspruch 1, wobei n 0 beträgt, jedes von XA, XB und/oder XC Wasserstoffe sind und R1 und R2 Gruppen sind, bei denen es sich nicht um Alkylgruppen handelt, die 1-3 Kohlenstoffatome aufweisen.
- Verbindung nach Anspruch 1, wobei n 0 beträgt, jedes von XA, XB und/oder XC Wasserstoffe sind und R1 und R2 Gruppen sind, bei denen es sich nicht um Ethyl- und Methylgruppen handelt.
- Verbindung nach Anspruch 1, wobei R1 und R2 Gruppen sind, bei denen es sich nicht um unsubstituierte Phenylgruppen handelt.
- Verbindung nach Anspruch 1, wobei n 0 beträgt und R1 und R2 Gruppen sind, bei denen es sich nicht um unsubstituierte Phenylgruppen handelt.
- Verbindung nach Anspruch 1, wobei n 0 beträgt, jedes von XA, XB und/oder XC Wasserstoffe sind und R1 und R2 Gruppen sind, bei denen es sich nicht um unsubstituierte Phenylgruppen handelt.
- Verbindung nach Anspruch 1, wobei mindestens eines von R1 und R2 [(-CH2)m-M-R3]: -(CH2)m-M-R3 ist, wobei m 0 beträgt oder eine ganze Zahl im Bereich von 1 bis 6 (bevorzugt 1 oder 2) ist, M ein cyclisches Alkylen, cyclisches Alkenylen, heterocyclisches Alkylen, Arylen oder Heteroarylen ist und R3 eine wahlweise substituierte Alkyl-, Alkenyl-, Alkynyl- oder Arylgruppe ist, die 2 bis 20 Kohlenstoffatome aufweist.
- Verbindung nach Anspruch 1, wobei OR2 durch Chlor ersetzt ist.
- Verbindung, die die Formel FX3C: aufweist, wobei: Y Chlor oder OR1 ist; n 0 oder 1 beträgt, R1 und R2 unabhängig von einander aus der Gruppe ausgewählt sind bestehend aus unsubstituierten Alkyl-, Alkenyl- oder Alkynylgruppen, die 1 bis 6 Kohlenstoffatome aufweisen; und X1, X2 und X3 unabhängig von einander H, Alkylgruppen, die 1-6 Kohlenstoffatome aufweisen, oder Alkoxidgruppen, die 1-6 Kohlenstoffatome aufweisen, sind.
- Verbindung nach Anspruch 38, wobei Y Chlor ist und n 0 beträgt.
- Verbindung nach Anspruch 38, wobei Y OR1 ist und n 0 beträgt.
- Verbindung nach Anspruch 38, wobei R1 und R2 Alkenylgruppen, die 2-6 Kohlenstoffatome aufweisen, oder Alkynylgruppen, die 2-6 Kohlenstoffatome aufweisen, sind.
- Verbindung nach Anspruch 38, wobei R1 und R2 Alkenylgruppen, die 2-6 Kohlenstoffatome aufweisen, oder Alkynylgruppen, die 2-6 Kohlenstoffatome aufweisen, sind und X1, X2 und X3 Wasserstoffe oder Alkoxygruppen sind, die 1-3 Kolenstoffatome aufweisen.
- Verbindung nach Anspruch 38, wobei R1 und R2 Alkenylgruppen, die 2-6 Kohlenstoffatome aufweisen, oder Alkynylgruppen, die 2-6 Kohlenstoffatome aufweisen, sind und X1, X2 und X3 Wasserstoffe oder Methoxygruppen sind.
- Verbindung nach Anspruch 38, wobei Y Chlor ist und R1 eine Alkenylgruppe, die 2-6 Kohlenstoffatome aufweist, oder eine Alkynylgruppe, die 2-6 Kohlenstoffatome aufweist, ist.
- Verbindung nach Anspruch 38, wobei R1, R2 oder beide Propyl-, Butyl-, Pentyl- oder Hexylgruppen, einschließlich aller Isomere derselben, sind.
- Verbindung nach Anspruch 38, wobei R1, R2 oder beide aus den Gruppen ausgewählt sind bestehend aus n-Propyl-, Isopropyl-, n-Butyl-, 1-Methylpropyl-, 2-Methylpropyl-, n-Pentyl-, 1-Methylbutyl-, 2-Methylbutyl-, 3-Methylbutyl-, 1-Ethylpropyl-, n-Hexyl-, 1-Methylpentyl-, 2- Methylpentyl-, 3-Methylpentyl-, 1-Ethylbutyl-, 2-Ethylbutyl-, 3-Ethylbutyl-, 1,2-Dimethylbutyl-, 2,3-Dimethylbutyl-, 1,1-Dimethylbutyl-, 2,2-Dimethylbutyl- oder 3,3-Dimethylbutylgruppen.
- Verbindung der Formel FX4: Formel FX4 wobei XA-C die oben angegebene Definition aufweisen, R' unabhängig von anderen R' im Molekül Wasserstoff oder wahlweise substituierte Alkyl-, Alkenyl-, Alkynyl- oder Arylgruppen sind und p eine ganze Zahl im Bereich von 2 bis 6 ist und p bevorzugt 2, 3 oder 4 beträgt.
- Verbindung der Formel FX4A: Formel FX4A wobei XA-C die oben angegebene Definition aufweisen, R' unabhängig von anderen R' im Molekül Wasserstoff oder wahlweise substituierte Alkyl-, Alkenyl-, Alkynyl- oder Arylgruppen sind und p eine ganze Zahl im Bereich von 2 bis 6 ist und p bevorzugt 2, 3 oder 4 beträgt.
- Verbindung der Formel FX5: Formel FX5 wobei XA-C und n die oben angegebene Definition aufweisen und m 0 beträgt oder eine ganze Zahl im Bereich von 1 bis 6 (bevorzugt 1 oder 2) ist, M ein Alkylen, Alkenylen, cyclisches Alkylen, cyclisches Alkenylen, Alkoxyalkyl, Alkoxyalkylen, Aminoalkyl, Aminoalkylen, heterocyclisches Alkylen, Arylen oder Heteroarylen ist und R3 eine wahlweise substituierte Alkyl-, Alkenyl-, Alkynyl- oder Arylgruppe ist, die 2-20 Kohlenstoffatome aufweist.
- Verbindung der Formel FX5B: Formel FX5B wobei XA-C und n die oben angegebene Definition aufweisen, Y ein Halogen, bevorzugt Chlor oder Fluor ist, m 0 beträgt oder eine ganze Zahl im Bereich von 1 bis 6 (bevorzugt 1 oder 2) ist, M ein cyclisches Alkylen, cyclisches Alkenylen, heterocyclisches Alkylen, Arylen oder Heteroarylen ist und R3 eine wahlweise substituierte Alkyl-, Alkenyl-, Alkynyl- oder Arylgruppe ist, die 2-20 Kohlenstoffatome aufweist.
- Verbindung, ausgewählt aus der Gruppe bestehend aus den Verbindungen CX1-CX17.
- Verbindung, ausgewählt aus der Gruppe bestehend aus den Verbindungen CX2 und CX4.
- Verbindung, ausgewählt aus der Gruppe bestehend aus den Verbindungen CX1, CX5, CX7, CX8, CX14, RPhos1, RPhos2 und RPhos8.
- Methode zum Verabreichen der Verbindung nach einem der Ansprüche 1-62, die dazu fähig ist, den Zelltod zu induzieren, an einen Patienten, der der Behandlung bedarf.
- Methode nach Anspruch 63, wobei die Verbindung einen IC50-Wert in einer Krebszelllinie von weniger als 50 Mikromolen aufweist.
- Methode nach Anspruch 63, wobei die Verbindung einen IC50-Wert in einer Krebszelllinie von weniger als 10 Mikromolen aufweist.
- Methode nach Anspruch 63, wobei die Verbindung einen IC50-Wert in einer Krebszelllinie von weniger als 1 Mikromol aufweist.
- Methode für das Behandeln einer Krebszelle, umfassend das Kontaktieren der Zelle mit einer therapeutisch wirksamen Menge einer Verbindung nach einem der Ansprüche 1-62.
- Methode für das Behandeln einer Krebszelle, umfassend das Kontaktieren der Zelle mit einer therapeutisch wirksamen Menge einer Kombination einer Verbindung nach einem der Ansprüche 1-62 und eines chemotherapeutischen Mittels, bei dem es sich nicht um die Verbindung handelt.
- Methode nach Anspruch 68, wobei das chemotherapeutische Mittel, bei dem es sich nicht um die Verbindung handelt, eines ist, das bei DNA Schäden verursacht.
- Methode nach Anspruch 68, wobei das chemotherapeutische Mittel eines ist, das die Mitose beeinflusst und schließlich zu einer G2-/M-Arretierung führt.
- Methode nach Anspruch 68, wobei das Mittel aus der Gruppe ausgewählt wird bestehend aus Cisplatin, Etoposid, Irinotecan, Camptostar, Topotecan, Paclitaxel, Docetaxel, Epothilonen, Taxoter, Taxol, Tamoxifen, 5-Fluorouacil, Methoxtrexat, Temozolomid, Cyclophosphamid, SCH 66336, R115777, L778,123, BMS 214662, IRESSAWZ (Gefitinib), TARCEVAWZ (Erlotinib-Hydrochlorid), Antikörper gegen EGFR, GLEEVECWZ (Imatinib), Intron, Ara-C, Adriamycin, Cytoxan, Gemcitabin, Uracil Senf, Chlormethin, Ifosfamid, Melphalan, Chlorambucil, Pipobroman, Triethylenmelamin, Triethylenthiophosphoramin, Busulfan, Carmustin, Lomustin, Streptozocin, Dacarbazin, Floxuridin, Cytarabin, 6-Mercaptopurin, 6-Thioguanin, Fludarabinphosphat, Pentostatin, Vinblastin, Vincristin, Vindesin, Bleomycin, Doxorubicin, Daclinomycin, Daunorubicin, Epirubicin, Idarubicin, Mithramycin, Deoxycoformycin, Mitomycin-C, L-Asparaginase, Tenipoid 17.alpha.-Ethinylstradiol, Diethylstilbestrol, Testosteron, Prednison, Fluoxymesteron, Dromostanolonpropionat, Testolacton, Megestrolacetat, Methylprednisolon, Methyltestosteron, Prednisolon, Triamcinolon, Chlortrianisen, Hydroxyprogesteron, Aminoglutethimid, Estramustin, Medroxyprogesteronacetat, Leuprolid, Flutamid, Toremifen, Goserelin, Carboplatin, Hydroxyharnstoff, Amsacrin, Procarbazin, Mitotan, Mitoxantron, Levamisol, Navelben, Anastrazol, Letrazol, Capecitabin, Reloxafin, Droloxafin, Hexamethylmelamin, Avastin, Herceptin, Bexxar, Velcad, Zevalin, Trisenox, Xeloda, Vinorelbin, Porfimer, ErtibuxWZ (Cetuximab), Liposomal, Thiotepa, Altretamin, Melphalan, Trastuzamab, Lerozol, Fulvestrant, Exemestan, Fulvestrant, Ifosfomid, Rituximab, C225 und Campath.
- Methode nach Anspruch 68, wobei das chemotherapeutische Mittel Dacarbazin, Etoposid, Doxorubicin, Camptothecin oder ein Analog oder Derivat derselben ist.
- Methode für die Modulation von Zelltod und/oder Apoptose in einer Zielzelle, umfassend das Kontaktieren der Zielzelle mit einer wirksamen Menge einer Verbindung nach einem der Ansprüche 1–62.
- Methode für die Modulation von Zelltod und/oder Apoptose in einer Zielzelle, umfassend das Kontaktieren der Zielzelle mit einer wirksamen Menge einer Kombination einer Verbindung nach einem der Ansprüche 1–62 und eines chemotherapeutischen Mittels, bei dem es sich nicht um die Verbindung handelt.
- Methode nach einem der Ansprüche 73 oder 74, wobei die Modulation durch Induktion erfolgt.
- Methode nach einem der Ansprüche 73 oder 74, wobei die Modulation durch Inhibierung erfolgt.
- Methode nach einem der Ansprüche 73 oder 74, wobei die Zielzelle eine Melanomzelle oder Kolonkrebszelle ist.
- Pharmazeutische Zusammensetzung umfassend eine therapeutisch wirksame Menge einer oder mehrerer Verbindungen nach einem der Ansprüche 1–62 und einen pharmazeutisch akzeptablen Träger oder ein pharmazeutisch akzeptables Vehikel.
- Pharmazeutische Zusammensetzung nach Anspruch 78, des Weiteren umfassend ein chemotherapeutisches Mittel, das DNA beschädigt.
- Pharmazeutische Zusammensetzung nach Anspruch 78, des Weiteren umfassend ein chemotherapeutisches Mittel, das die Mitose einer Zelle beeinflusst.
- Medikament umfassend eine oder mehrere der Verbindungen nach einem der Ansprüche 1–62.
- Methode für die Herstellung eines Medikaments zum Induzieren der Apoptose, Modulieren der Caspaseaktivität, Induzieren des Zelltods oder Behandeln von Krebs, die das Einarbeiten einer therapeutisch wirksamen Menge einer oder mehrerer der Verbindungen nach einem der Ansprüche 1–62 in eine pharmazeutisch akzeptable Rezeptur umfasst.
- Methode für das Behandeln eines Patienten, der der Behandlung gegen Krebs bedarf, umfassend das Verabreichen einer therapeutisch wirksamen Menge einer oder mehrerer Verbindungen nach einem der Ansprüche 1–62 oder einer pharmazeutisch akzeptablen Rezeptur derselben an den Patienten.
- Methode nach Anspruch 83, wobei der Typ Krebs aus der Gruppe ausgewählt ist bestehend aus Hautkrebs, Brustkrebs und Kolonkrebs.
- Methode nach Anspruch 83, wobei der Typ Krebs aus der Gruppe ausgewählt ist bestehend aus Lungenkrebs, Prostatakrebs, Lymphom, Leukämie, Krebs des Gehirns oder Zentralnervensystems (ZNS), Neuroblastom, Eierstockkrebs, Nierenkrebs, soliden Tumoren und Bluttumoren.
- Methode nach Anspruch 83, wobei der Typ Krebs aus der Gruppe ausgewählt ist bestehend am nicht kleinzelligem Lungenkrebs, akuter lymphozytärer Leukämie (ALL), akuter myeloischer Leukämie (AML) und chronischer myeloischer Leukämie (CML).
- Methode zum Behandeln eines Patienten, der der Behandlung gegen Melanom bedarf, umfassend das Verabreichen einer therapeutisch wirksamen Menge einer oder mehrerer Verbindungen nach einem der Ansprüche 1–62 oder einer pharmazeutisch akzeptablen Rezeptur derselben an den Patienten.
- Pharmazeutische Zusammensetzung umfassend eine therapeutisch wirksame Menge einer oder mehrerer Verbindung ausgewählt aus der Gruppe bestehend aus den Verbindungen CX1, CX5, CX7, CX8, CX14, RPhos1, RPhos2 und RPhos8 und eines pharmazeutisch akzeptablen Trägers oder Vehikels.
- Methode für die Herstellung eines Medikaments zum Induzieren der Apoptose, Modulieren der Caspaseaktivität, Induzieren des Zelltods oder Behandeln von Krebs, die das Einarbeiten einer therapeutisch wirksamen Menge einer oder mehrerer der Verbindungen ausgewählt aus der Gruppe bestehend aus CX1, CX5, CX7, CX8, CX14, RPhos1, RPhos2 und RPhos8 in eine pharmazeutisch akzeptable Rezeptur umfasst.
- Verbindung ausgewählt aus der Gruppe bestehend aus den Verbindungen CX7, CX8 und CX14.
- Pharmazeutische Zusammensetzung umfassend eine therapeutisch wirksame Menge einer oder mehrerer Verbindungen ausgewählt aus der Gruppe bestehend aus den Verbindungen CX7, CX8 und CX14 und einem pharmazeutisch akzeptablen Träger oder Vehikel.
- Methode für die Herstellung eines Medikaments zum Induzieren der Apoptose, Modulieren der Caspaseaktivität, Induzieren des Zelltods oder Behandeln von Krebs, die das Einarbeiten einer therapeutisch wirksamen Menge einer oder mehrerer der Verbindungen ausgewählt aus der Gruppe bestehend am CX7, CX8 und CX14 in eine pharmazeutisch akzeptable Rezeptur umfasst.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42143502P | 2002-10-25 | 2002-10-25 | |
| US42126302P | 2002-10-25 | 2002-10-25 | |
| US421263P | 2002-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE08020700T1 true DE08020700T1 (de) | 2009-08-13 |
Family
ID=32179849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE08020700T Pending DE08020700T1 (de) | 2002-10-25 | 2003-10-27 | Zusammensetzungen mit fluorosubstituierten Olefinen |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7534366B2 (de) |
| EP (23) | EP2277968A3 (de) |
| JP (11) | JP2006503961A (de) |
| KR (4) | KR101319864B1 (de) |
| CN (10) | CN106085362A (de) |
| AT (3) | ATE529491T1 (de) |
| AU (3) | AU2003284352A1 (de) |
| BR (2) | BRPI0315633B1 (de) |
| CA (1) | CA2503421C (de) |
| CY (3) | CY1118652T1 (de) |
| DE (1) | DE08020700T1 (de) |
| DK (7) | DK2258404T3 (de) |
| ES (9) | ES2728672T3 (de) |
| HU (3) | HUE049351T2 (de) |
| IL (2) | IL168198A (de) |
| MX (1) | MXPA05004292A (de) |
| PT (5) | PT2314654T (de) |
| RU (3) | RU2395555C2 (de) |
| SG (1) | SG194236A1 (de) |
| SI (2) | SI3170880T1 (de) |
| TR (1) | TR201908011T4 (de) |
| TW (2) | TW200418970A (de) |
| WO (2) | WO2004037752A2 (de) |
| ZA (1) | ZA200504236B (de) |
Families Citing this family (317)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050096246A1 (en) * | 2003-11-04 | 2005-05-05 | Johnson Robert C. | Solvent compositions containing chlorofluoroolefins |
| US20040089839A1 (en) * | 2002-10-25 | 2004-05-13 | Honeywell International, Inc. | Fluorinated alkene refrigerant compositions |
| AU2015200222B2 (en) * | 2002-10-25 | 2016-05-26 | Honeywell International, Inc | Compositions containing flourine substituted olefins |
| WO2007109748A2 (en) * | 2006-03-21 | 2007-09-27 | Honeywell International Inc. | Foaming agents containing fluorine substituted unsaturated olefins |
| US7833433B2 (en) * | 2002-10-25 | 2010-11-16 | Honeywell International Inc. | Heat transfer methods using heat transfer compositions containing trifluoromonochloropropene |
| US9005467B2 (en) | 2003-10-27 | 2015-04-14 | Honeywell International Inc. | Methods of replacing heat transfer fluids |
| US20090253820A1 (en) * | 2006-03-21 | 2009-10-08 | Honeywell International Inc. | Foaming agents and compositions containing fluorine sustituted olefins and methods of foaming |
| US8033120B2 (en) * | 2002-10-25 | 2011-10-11 | Honeywell International Inc. | Compositions and methods containing fluorine substituted olefins |
| US10011698B2 (en) * | 2002-10-25 | 2018-07-03 | Honeywell International Inc. | Foaming agents, foamable compositions, foams and articles containing fluorine substituted olefins, and methods of making same |
| US7279451B2 (en) * | 2002-10-25 | 2007-10-09 | Honeywell International Inc. | Compositions containing fluorine substituted olefins |
| CA2503421C (en) | 2002-10-25 | 2015-01-06 | Rajiv R. Singh | Compositions containing fluorine substituted olefins |
| US9796848B2 (en) | 2002-10-25 | 2017-10-24 | Honeywell International Inc. | Foaming agents and compositions containing fluorine substituted olefins and methods of foaming |
| US9994750B2 (en) * | 2002-10-25 | 2018-06-12 | Honeywell International Inc. | Compositions containing fluorine substituted olefins and methods and systems using same |
| US7563936B2 (en) | 2006-10-27 | 2009-07-21 | Honeywell International Inc | Processes for geometric isomerization of halogenated olefins |
| US8530708B2 (en) | 2003-07-25 | 2013-09-10 | Honeywell International Inc. | Processes for selective dehydrohalogenation of halogenated alkanes |
| US7880040B2 (en) * | 2004-04-29 | 2011-02-01 | Honeywell International Inc. | Method for producing fluorinated organic compounds |
| US7524805B2 (en) * | 2004-04-29 | 2009-04-28 | Honeywell International Inc. | Azeotrope-like compositions of tetrafluoropropene and hydrofluorocarbons |
| US20180161076A1 (en) | 2003-10-27 | 2018-06-14 | Honeywell International Inc. | Foaming agents and compositions containing fluorine substituted olefins, and methods of foaming |
| US9499729B2 (en) | 2006-06-26 | 2016-11-22 | Honeywell International Inc. | Compositions and methods containing fluorine substituted olefins |
| US7655610B2 (en) * | 2004-04-29 | 2010-02-02 | Honeywell International Inc. | Blowing agent compositions comprising fluorinated olefins and carbon dioxide |
| US9308199B2 (en) * | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
| RU2006120452A (ru) | 2003-11-13 | 2007-12-27 | Е.И.Дюпон де Немур энд Компани (US) | Композиции и способы уменьшения опасности воспламенения воспламеняющихся холодильных агентов |
| US20050163652A1 (en) * | 2004-01-23 | 2005-07-28 | Metzger Richard N. | Low level ultraviolet disinfecting system |
| US7098176B2 (en) * | 2004-04-16 | 2006-08-29 | Honeywell International Inc. | Azeotrope-like compositions of tetrafluoropropene and pentafluoropropene |
| US7074751B2 (en) * | 2004-04-16 | 2006-07-11 | Honeywell International Inc. | Azeotrope-like compositions of tetrafluoropropene and trifluoroiodomethane |
| CN101124288A (zh) * | 2004-04-16 | 2008-02-13 | 霍尼韦尔国际公司 | 类共沸三氟碘甲烷组合物 |
| EP1735400B1 (de) * | 2004-04-16 | 2018-01-24 | Honeywell International Inc. | Azeotropartige zusammensetzungen aus tetrafluorpropen und pentafluorpropen |
| US7605117B2 (en) * | 2004-04-16 | 2009-10-20 | Honeywell International Inc. | Methods of replacing refrigerant |
| US8084653B2 (en) | 2004-04-29 | 2011-12-27 | Honeywell International, Inc. | Method for producing fluorinated organic compounds |
| AU2012202525B2 (en) * | 2004-04-29 | 2014-08-14 | Honeywell International, Inc. | Compositions containing fluorine substituted olefins |
| JP4864879B2 (ja) * | 2004-04-29 | 2012-02-01 | ハネウェル・インターナショナル・インコーポレーテッド | 1,3,3,3−テトラフルオロプロペンの合成方法 |
| AU2014277871B2 (en) * | 2004-04-29 | 2016-06-30 | Honeywell International, Inc. | Compositions containing fluorine substituted olefins |
| US8008244B2 (en) * | 2004-04-29 | 2011-08-30 | Honeywell International Inc. | Compositions of tetrafluoropropene and hydrocarbons |
| US9024092B2 (en) * | 2006-01-03 | 2015-05-05 | Honeywell International Inc. | Method for producing fluorinated organic compounds |
| AU2013203638B2 (en) * | 2004-04-29 | 2014-09-25 | Honeywell International, Inc. | Compositions containing fluorine substituted olefins |
| US8383867B2 (en) | 2004-04-29 | 2013-02-26 | Honeywell International Inc. | Method for producing fluorinated organic compounds |
| US7659434B2 (en) * | 2004-04-29 | 2010-02-09 | Honeywell International Inc. | Method for producing fluorinated organic compounds |
| US7674939B2 (en) * | 2004-04-29 | 2010-03-09 | Honeywell International Inc. | Method for producing fluorinated organic compounds |
| US7951982B2 (en) * | 2004-04-29 | 2011-05-31 | Honeywell International Inc. | Method for producing fluorinated organic compounds |
| US7428816B2 (en) * | 2004-07-16 | 2008-09-30 | Honeywell International Inc. | Working fluids for thermal energy conversion of waste heat from fuel cells using Rankine cycle systems |
| US20080111100A1 (en) | 2006-11-14 | 2008-05-15 | Thomas Raymond H | Use of low gwp refrigerants comprising cf3i with stable lubricants |
| MX2007007457A (es) * | 2004-12-21 | 2007-08-20 | Honeywell Int Inc | Compuestos estabilizados de yodocarbono. |
| US9175201B2 (en) | 2004-12-21 | 2015-11-03 | Honeywell International Inc. | Stabilized iodocarbon compositions |
| WO2006081433A1 (en) * | 2005-01-26 | 2006-08-03 | Marvin Lumber And Cedar Company | Flashing assembly with cross channels and method for same |
| PL3309233T5 (pl) * | 2005-03-04 | 2024-05-27 | The Chemours Company Fc, Llc | Kompozycje zawierające hfc-1234yf i hfc-152a |
| US20060243944A1 (en) * | 2005-03-04 | 2006-11-02 | Minor Barbara H | Compositions comprising a fluoroolefin |
| AU2016200229B2 (en) * | 2005-03-04 | 2017-03-09 | The Chemours Company Fc, Llc. | Compositions comprising a fluoroolefin |
| US7569170B2 (en) * | 2005-03-04 | 2009-08-04 | E.I. Du Pont De Nemours And Company | Compositions comprising a fluoroolefin |
| US20220389297A1 (en) | 2005-03-04 | 2022-12-08 | The Chemours Company Fc, Llc | Compositions comprising a fluoroolefin |
| RU2418027C2 (ru) * | 2005-03-04 | 2011-05-10 | Е.И.Дюпон Де Немур Энд Компани | Композиция охладителя или теплоносителя, способ применения композиции, способ охлаждения или обогрева, установки, содержащие композицию, способ детектирования композиции в установке, вспенивающий агент, содержащий композицию, способ получения пены, распыляемая композиция, способ получения аэрозольных продуктов, способ подавления пламени или гашения, а также способ обработки участка инертным газом для предотвращения возгорания |
| AU2014202510B2 (en) * | 2005-03-04 | 2015-10-15 | The Chemours Company Fc, Llc. | Compositions comprising a fluoroolefin |
| CN110003859A (zh) * | 2005-03-04 | 2019-07-12 | 科慕埃弗西有限公司 | 包含氟代烯烃的组合物 |
| EP1858485B1 (de) * | 2005-03-16 | 2013-09-11 | Honeywell International Inc. | Medikamentenabgabeformulierungen, vorrichtungen und verfahren |
| JP4627045B2 (ja) * | 2005-04-27 | 2011-02-09 | セントラル硝子株式会社 | 金属製造保護ガス |
| TW201815923A (zh) * | 2005-06-24 | 2018-05-01 | 美商哈尼威爾國際公司 | 含有經氟取代之烯烴之發泡劑及組合物,及發泡方法 |
| TWI645031B (zh) * | 2005-06-24 | 2018-12-21 | 哈尼威爾國際公司 | 含有經氟取代之烯烴之組合物及其用途 |
| AU2011213796B2 (en) * | 2005-06-24 | 2012-09-27 | Honeywell International Inc. | Compositions containing fluorine substituted olefins |
| US8420706B2 (en) * | 2005-06-24 | 2013-04-16 | Honeywell International Inc. | Foaming agents, foamable compositions, foams and articles containing halogen substituted olefins, and methods of making same |
| US8574451B2 (en) * | 2005-06-24 | 2013-11-05 | Honeywell International Inc. | Trans-chloro-3,3,3-trifluoropropene for use in chiller applications |
| AU2013203977B2 (en) * | 2005-06-24 | 2016-05-26 | Honeywell International Inc. | Compositions containing fluorine substituted olefins |
| US7496002B2 (en) * | 2005-08-03 | 2009-02-24 | Nekton Research Llc | Water submersible electronics assembly and methods of use |
| KR101399203B1 (ko) * | 2005-11-01 | 2014-05-27 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 플루오로올레핀을 포함하는 조성물 및 그의 용도 |
| US7708903B2 (en) | 2005-11-01 | 2010-05-04 | E.I. Du Pont De Nemours And Company | Compositions comprising fluoroolefins and uses thereof |
| US20070100010A1 (en) * | 2005-11-01 | 2007-05-03 | Creazzo Joseph A | Blowing agents for forming foam comprising unsaturated fluorocarbons |
| CA2625365A1 (en) * | 2005-11-01 | 2007-05-10 | E.I. Dupont De Nemours And Company | Blowing agents for forming foam comprising unsaturated fluorocarbons |
| US7423188B2 (en) | 2005-11-01 | 2008-09-09 | E. I. Du Pont De Nemours And Company | Azeotrope compositions comprising E-1,3,3,3-tetrafluoropropene and hydrogen fluoride and uses thereof |
| WO2007053673A2 (en) * | 2005-11-01 | 2007-05-10 | E. I. Du Pont De Nemours And Company | Solvent compositions comprising unsaturated fluorinated hydrocarbons |
| US8287752B2 (en) * | 2005-11-01 | 2012-10-16 | E I Du Pont De Nemours And Company | Fire extinguishing and fire suppression compositions comprising unsaturated fluorocarbons |
| CA2626183C (en) * | 2005-11-01 | 2016-11-29 | E. I. Du Pont De Nemours And Company | Compositions comprising fluoroolefins and uses thereof |
| AU2012229664B2 (en) * | 2005-11-01 | 2015-03-05 | The Chemours Company Fc, Llc. | Compositions comprising fluoroolefins and uses thereof |
| AU2015202652B2 (en) * | 2005-11-01 | 2016-11-24 | The Chemours Company Fc, Llc. | Compositions comprising fluoroolefins and uses thereof |
| US20070098646A1 (en) * | 2005-11-01 | 2007-05-03 | Nappa Mario J | Aerosol propellants comprising unsaturated fluorocarbons |
| AU2015218556B2 (en) * | 2005-11-01 | 2017-03-16 | The Chemours Company Fc, Llc. | Fire extinguishing and fire suppression compositions comprising unsaturated fluorocarbons |
| US7902410B2 (en) | 2005-11-03 | 2011-03-08 | Honeywell International Inc. | Process for the manufacture of fluorinated alkanes |
| US8148584B2 (en) | 2005-11-10 | 2012-04-03 | E.I. Du Pont De Nemours And Company | Compositions, combustion prevention compositions, methods for preventing and/or extinguishing combustion, combustion prevention systems, and production processes |
| US7759532B2 (en) | 2006-01-13 | 2010-07-20 | E.I. Du Pont De Nemours And Company | Refrigerant additive compositions containing perfluoropolyethers |
| US8188323B2 (en) * | 2006-01-13 | 2012-05-29 | E.I. Du Pont De Nemours And Company | Refrigerant compositions containing perfluoropolyethers |
| US20070210276A1 (en) * | 2006-03-10 | 2007-09-13 | Honeywell International Inc. | Method for generating pollution credits |
| US9000061B2 (en) | 2006-03-21 | 2015-04-07 | Honeywell International Inc. | Foams and articles made from foams containing 1-chloro-3,3,3-trifluoropropene (HFCO-1233zd) |
| FR2899234B1 (fr) * | 2006-03-31 | 2017-02-17 | Arkema | Composition d'agent d'expansion |
| RU2399607C2 (ru) * | 2006-04-03 | 2010-09-20 | Е.И.Дюпон Де Немур Энд Компани | Селективно взаимодействующие олефины, содержащие концевую группу cf2, в смеси |
| US7337486B2 (en) | 2006-04-25 | 2008-03-04 | Leatherman Tool Group, Inc. | Hand tool |
| GB0611742D0 (en) | 2006-06-14 | 2006-07-26 | Ineos Fluor Holdings Ltd | Desiccants for fluids |
| GB0614067D0 (en) * | 2006-07-17 | 2006-08-23 | Ineos Fluor Holdings Ltd | Heat transfer compositions |
| DE202007008291U1 (de) * | 2006-06-17 | 2007-10-18 | Ineos Fluor Holdings Ltd., Runcorn | Wärmeübertragungszusammensetzungen |
| US8377327B2 (en) * | 2006-06-27 | 2013-02-19 | E I Du Pont De Nemours And Company | Tetrafluoropropene production processes |
| US20100242677A1 (en) * | 2006-07-03 | 2010-09-30 | Honeywell International Inc. | Non-ferrous metal cover gases |
| US20080003127A1 (en) * | 2006-07-03 | 2008-01-03 | Honeywell International Inc. | Non-Ferrous Metal Cover Gases |
| EP2044167A1 (de) * | 2006-07-12 | 2009-04-08 | Solvay Fluor GmbH | Verfahren zum heizen und kühlen unter verwendung von fluoretherverbindungen, dafür geeignete zusammensetzungen und deren verwendung |
| JP5764291B2 (ja) * | 2006-07-13 | 2015-08-19 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company | テトラフルオロプロペンおよびペンタフルオロプロペンを製造するための触媒製造方法 |
| WO2008009923A2 (en) * | 2006-07-17 | 2008-01-24 | Ineos Fluor Holdings Limited | Heat transfer compositions |
| GB0614080D0 (en) * | 2006-07-17 | 2006-08-23 | Ineos Fluor Holdings Ltd | Heat transfer compositions |
| US7563384B2 (en) * | 2006-07-28 | 2009-07-21 | Honeywell International Inc. | Essentially non-flammable low global warming compositions |
| EP2118229A2 (de) * | 2006-09-01 | 2009-11-18 | E.I. Du Pont De Nemours And Company | Verfahren zur zirkulierung spezieller wärmeübertragungsflüssigkeiten durch geschlossene kreise |
| EP2069455A1 (de) * | 2006-09-01 | 2009-06-17 | E.I. Du Pont De Nemours And Company | Terpen-, terpenoid- und fullerenstabilisatoren für fluorolefine |
| US8007677B2 (en) * | 2006-09-08 | 2011-08-30 | E.I. Du Pont De Nemours And Company | Azeotrope compositions comprising 1,1,1,2,3-pentafluoropropene and hydrogen fluoride and uses thereof |
| MX337217B (es) | 2006-10-03 | 2016-02-18 | Mexichem Amanco Holding Sa | Procedimiento de dehidrogenacion-halogenacion para la produccion de (hidro)fluoroalquenos de c3-c6. |
| US8013194B2 (en) | 2008-03-14 | 2011-09-06 | Honeywell International Inc. | Process for the manufacture of fluorinated olefins |
| EP2094630A2 (de) * | 2006-10-31 | 2009-09-02 | E.I. Du Pont De Nemours And Company | Herstellungsverfahren und zusammensetzungen, die 2,3,3,3-tetrafluorpropen und/oder 1,2,3,3-tetrafluorpropen enthalten |
| JP5139665B2 (ja) | 2006-11-02 | 2013-02-06 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| JP5179043B2 (ja) | 2006-11-06 | 2013-04-10 | 出光興産株式会社 | 冷凍機油組成物 |
| TW200838835A (en) | 2006-11-15 | 2008-10-01 | Du Pont | Processes for producing pentafluoropropenes and azeotropes comprising HF and certain halopropenes of the formula C3CI2F4, C3CIF5, or C3HF5 |
| WO2008065011A1 (en) * | 2006-11-29 | 2008-06-05 | Solvay Fluor Gmbh | Compositions comprising unsaturated hydrofluorocarbon compounds, and methods for heating and cooling using the compositions |
| WO2008076272A2 (en) | 2006-12-15 | 2008-06-26 | E. I. Du Pont De Nemours And Company | Compositions comprising 1,2,3,3,3-pentafluoropropene with z- and e-isomer ratio optimized for refrigeration performance |
| JP5914912B2 (ja) * | 2007-02-27 | 2016-05-11 | Jxエネルギー株式会社 | 冷凍機油および冷凍機用作動流体組成物 |
| JP5572284B2 (ja) * | 2007-02-27 | 2014-08-13 | Jx日鉱日石エネルギー株式会社 | 冷凍機油および冷凍機用作動流体組成物 |
| JP2009074018A (ja) * | 2007-02-27 | 2009-04-09 | Nippon Oil Corp | 冷凍機油および冷凍機用作動流体組成物 |
| US7597818B2 (en) * | 2007-02-27 | 2009-10-06 | Honeywell International Inc. | Azeotrope-like compositions of tetrafluoropropenes and bromofluoropropenes |
| EP2119760B1 (de) | 2007-03-08 | 2018-10-31 | Idemitsu Kosan Co., Ltd. | Zusammensetzung zum schmieren einer verdichtungskältemaschine |
| JP5522895B2 (ja) * | 2007-03-14 | 2014-06-18 | Jx日鉱日石エネルギー株式会社 | 冷凍機油および冷凍機用作動流体組成物 |
| JP5196823B2 (ja) * | 2007-03-27 | 2013-05-15 | Jx日鉱日石エネルギー株式会社 | 冷凍機油及び冷凍機用作動流体組成物 |
| JP5193485B2 (ja) | 2007-03-27 | 2013-05-08 | Jx日鉱日石エネルギー株式会社 | 冷凍機油及び冷凍機用作動流体組成物 |
| RU2466157C2 (ru) * | 2007-03-27 | 2012-11-10 | ДАУ ГЛОБАЛ ТЕКНОЛОДЖИЗ ЭлЭлСи | Высококачественная полимерная пена из фторированных алкеновых пенообразователей |
| CN101652412B (zh) * | 2007-03-29 | 2012-07-25 | 阿科玛股份有限公司 | 氢氟丙烯与氢氯氟烯烃的发泡剂组合物 |
| US8895635B2 (en) | 2007-03-29 | 2014-11-25 | Arkema Inc. | Blowing agent compositions of hydrochlorofluoroolefins |
| CN101652411B (zh) * | 2007-03-29 | 2013-01-23 | 阿科玛股份有限公司 | 氢氟烯烃类与氢氯氟烯烃类的发泡剂组合物 |
| US11208536B2 (en) | 2007-03-29 | 2021-12-28 | Arkema Inc. | Blowing agent compositions of hydrofluoroolefins and hydrochlorofluoroolefins |
| US9206297B2 (en) | 2007-03-29 | 2015-12-08 | Arkema Inc. | Blowing agent compositions of hydrochlorofluoroolefins |
| US11091602B2 (en) | 2007-03-29 | 2021-08-17 | Arkema Inc. | Blowing agent compositions of carbon dioxide and hydrochlorofluoroolefins |
| GB0706978D0 (en) | 2007-04-11 | 2007-05-16 | Ineos Fluor Holdings Ltd | Process |
| US8114828B2 (en) * | 2007-04-16 | 2012-02-14 | Honeywell International Inc. | Azeotrope-like compositions of tetrafluoropropene and alcohols |
| EP2138558B1 (de) | 2007-04-18 | 2016-04-13 | Idemitsu Kosan Co., Ltd. | Verwendung einer schmierölzusammensetzung für kühlanlagen und ein kompressor, enthaltend die schmierölzusammensetzung |
| JP5226242B2 (ja) | 2007-04-18 | 2013-07-03 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| JP2008267251A (ja) | 2007-04-19 | 2008-11-06 | Sanden Corp | 圧縮機 |
| JP2008267680A (ja) * | 2007-04-19 | 2008-11-06 | Sanden Corp | 冷凍回路 |
| KR20150059799A (ko) * | 2007-04-27 | 2015-06-02 | 이 아이 듀폰 디 네모아 앤드 캄파니 | Z-1,1,1,4,4,4-헥사플루오로-2-부텐의 공비 및 공비-유사 조성물 |
| ES2575130T3 (es) * | 2007-05-11 | 2016-06-24 | The Chemours Company Fc, Llc | Método para el intercambio de calor en un sistema de transferencia de calor por compresión de vapor y un sistema de transferencia de calor por compresión de vapor que comprende un intercambiador de calor intermedio con un evaporador o condensador de doble fila |
| US7972525B2 (en) | 2007-06-06 | 2011-07-05 | E. I. Du Pont De Nemours And Company | Azeotropic and azeotrope-like compositions of E-1,1,1,4,4,4-hexafluoro-2-butene |
| MX2009013468A (es) * | 2007-06-12 | 2010-01-27 | Denso Corp | Composicion lubricante para refrigerador y compresor que utiliza la misma. |
| JP2008308610A (ja) | 2007-06-15 | 2008-12-25 | Idemitsu Kosan Co Ltd | 冷凍機油組成物 |
| AU2008279420A1 (en) * | 2007-07-20 | 2009-01-29 | E. I. Du Pont De Nemours And Company | Compositions and use of trans-1,1,1,4,4,4-hexafluoro-2-butene foam-forming composition in the preparation of polyisocyanate-based foams |
| CN101765648A (zh) * | 2007-07-27 | 2010-06-30 | 纳幕尔杜邦公司 | 包含含氟烯烃的组合物及其用途 |
| JP5530929B2 (ja) | 2007-09-06 | 2014-06-25 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | E−1,1,1,4,4,5,5,5−オクタフルオロ−2−ペンテンの共沸および共沸混合物様組成物 |
| PL2185488T3 (pl) | 2007-09-13 | 2018-04-30 | Arkema Inc. | Kompozycje zawierające połączenie stereoizomerów Z i E fluorowodoroolefin |
| US8287579B2 (en) * | 2007-09-17 | 2012-10-16 | Thermage, Inc. | Method of using cryogenic compositions for cooling heated skin |
| GB2457345B (en) * | 2007-10-12 | 2012-02-08 | Ineos Fluor Holdings Ltd | Heat transfer compositions |
| US8333901B2 (en) | 2007-10-12 | 2012-12-18 | Mexichem Amanco Holding S.A. De C.V. | Heat transfer compositions |
| GB201002625D0 (en) * | 2010-02-16 | 2010-03-31 | Ineos Fluor Holdings Ltd | Heat transfer compositions |
| US20090099273A1 (en) * | 2007-10-12 | 2009-04-16 | Williams David J | Non-silicone surfactants for polyurethane or polyisocyanurate foam containing halogenated olefins as blowing agents |
| US8628681B2 (en) | 2007-10-12 | 2014-01-14 | Mexichem Amanco Holding S.A. De C.V. | Heat transfer compositions |
| US9550854B2 (en) * | 2007-10-12 | 2017-01-24 | Honeywell International Inc. | Amine catalysts for polyurethane foams |
| WO2009047535A2 (en) * | 2007-10-12 | 2009-04-16 | Ineos Fluor Holdings Limited | Heat transfer compositions |
| US8512591B2 (en) | 2007-10-12 | 2013-08-20 | Mexichem Amanco Holding S.A. De C.V. | Heat transfer compositions |
| EP2233553A4 (de) * | 2007-10-29 | 2011-08-31 | Nippon Oil Corp | Kühlschranköl und arbeitsfluidzusammensetzung für kältemaschine |
| US7479238B1 (en) * | 2007-11-06 | 2009-01-20 | Arkema Inc. | Azeotrope-like composition of 1,1,1-trifluoro-3-chloropropene and methyl formate |
| WO2009061002A1 (en) * | 2007-11-09 | 2009-05-14 | Daikin Industries, Ltd. | Hfc-1225ye-containing refrigerant and refrigerant composition containing the refrigerant |
| US8568609B2 (en) | 2007-11-22 | 2013-10-29 | Idemitsu Kosan Co., Ltd. | Lubricating oil composition for refrigerating machine |
| CN101970624A (zh) | 2007-11-22 | 2011-02-09 | 出光兴产株式会社 | 冷冻机用润滑油组合物及使用该组合物的压缩机 |
| EP2215154B1 (de) | 2007-11-29 | 2017-12-20 | The Chemours Company FC, LLC | Zusammensetzungen und verwendung einer cis-1,1,1,4,4,4-hexafluor-2-buten-schaumstoffformungszusammensetzung bei der herstellung von schaumstoffen auf polyisocyanat-basis |
| US8101672B2 (en) * | 2007-12-13 | 2012-01-24 | Honeywell International Inc. | Azeotrope-like compositions of 1,1,2,3,3-pentafluoropropene |
| CA2708274C (en) | 2007-12-19 | 2016-10-18 | E. I. Du Pont De Nemours And Company | Foam-forming compositions containing azeotropic or azeotrope-like mixtures containing z-1,1,1,4,4,4-hexafluoro-2-butene and their uses in the preparation of polyisocyanate-based foams |
| JP5241262B2 (ja) | 2008-02-15 | 2013-07-17 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| JP5241261B2 (ja) | 2008-02-15 | 2013-07-17 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| JP5241263B2 (ja) | 2008-02-15 | 2013-07-17 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| JP2009222357A (ja) * | 2008-02-18 | 2009-10-01 | Daikin Ind Ltd | 冷凍装置 |
| EP3831800A1 (de) | 2008-02-21 | 2021-06-09 | The Chemours Company FC, LLC | Azeotropzusammensetzungen mit 3,3,3-trifluoropropen und wasserstofffluorid sowie verfahren zur verwendung davon |
| JP5612250B2 (ja) | 2008-03-07 | 2014-10-22 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| US7442321B1 (en) * | 2008-03-07 | 2008-10-28 | Arkema Inc. | Azeotrope-like composition of 1,1,1-trifluoro-3-chloropropene and trans-1,2-dichloroethylene |
| US8710282B2 (en) | 2008-03-14 | 2014-04-29 | Honeywell International Inc. | Integrated process for the manufacture of fluorinated olefins |
| JP5176624B2 (ja) * | 2008-03-18 | 2013-04-03 | ダイキン工業株式会社 | 冷凍装置 |
| JP2009222359A (ja) * | 2008-03-18 | 2009-10-01 | Daikin Ind Ltd | 冷凍装置 |
| JP2009222360A (ja) * | 2008-03-18 | 2009-10-01 | Daikin Ind Ltd | 熱交換器 |
| JP2009222348A (ja) * | 2008-03-18 | 2009-10-01 | Daikin Ind Ltd | 冷凍装置 |
| JP2009222032A (ja) * | 2008-03-18 | 2009-10-01 | Daikin Ind Ltd | 冷凍装置 |
| JP2009257744A (ja) * | 2008-03-25 | 2009-11-05 | Daikin Ind Ltd | 冷凍装置 |
| US8322149B2 (en) * | 2008-04-01 | 2012-12-04 | Honeywell International Inc. | Method for selecting lubricants for heat pumps |
| US9994751B2 (en) * | 2008-04-30 | 2018-06-12 | Honeywell International Inc. | Absorption refrigeration cycles using a LGWP refrigerant |
| KR102884920B1 (ko) * | 2008-05-07 | 2025-11-12 | 더 케무어스 컴퍼니 에프씨, 엘엘씨 | 1,1,1,2,3-펜타플루오로프로판 또는 2,3,3,3-테트라플루오로프로펜을 포함하는 조성물 |
| JP2009270496A (ja) * | 2008-05-08 | 2009-11-19 | Sanden Corp | 圧縮機およびそれを用いた冷凍サイクル |
| FR2932494B1 (fr) | 2008-06-11 | 2011-02-25 | Arkema France | Compositions a base d'hydrofluoroolefines |
| FR2932492B1 (fr) | 2008-06-11 | 2010-07-30 | Arkema France | Compositions a base d'hydrofluoroolefines |
| FR2932493B1 (fr) | 2008-06-11 | 2010-07-30 | Arkema France | Compositions a base d'hydrofluoroolefines |
| JP5669343B2 (ja) * | 2008-06-16 | 2015-02-12 | 三菱電機株式会社 | 冷凍サイクル装置 |
| CN102066852B (zh) * | 2008-06-16 | 2014-03-05 | 三菱电机株式会社 | 非共沸混合制冷剂及冷冻循环装置 |
| JP2010002105A (ja) * | 2008-06-19 | 2010-01-07 | Mitsubishi Electric Corp | 冷凍サイクル装置 |
| JP5014271B2 (ja) * | 2008-06-24 | 2012-08-29 | 三菱電機株式会社 | 冷凍サイクル装置 |
| US20100016457A1 (en) * | 2008-07-16 | 2010-01-21 | Bowman James M | Hfo-1234ze mixed isomers with hfc-245fa as a blowing agent, aerosol, and solvent |
| US8820079B2 (en) * | 2008-12-05 | 2014-09-02 | Honeywell International Inc. | Chloro- and bromo-fluoro olefin compounds useful as organic rankine cycle working fluids |
| CN107384323A (zh) * | 2008-07-30 | 2017-11-24 | 霍尼韦尔国际公司 | 含有二氟甲烷和氟取代的烯烃的组合物 |
| US11214720B2 (en) | 2009-07-29 | 2022-01-04 | Honeywell International Inc. | Compositions containing difluoromethane and fluorine substituted olefins |
| FR2936806B1 (fr) | 2008-10-08 | 2012-08-31 | Arkema France | Fluide refrigerant |
| FR2937328B1 (fr) | 2008-10-16 | 2010-11-12 | Arkema France | Procede de transfert de chaleur |
| US20170080773A1 (en) | 2008-11-03 | 2017-03-23 | Arkema France | Vehicle Heating and/or Air Conditioning Method |
| US20100119460A1 (en) * | 2008-11-11 | 2010-05-13 | Honeywell International Inc. | Azeotrope-Like Compositions Of 2,3,3,3-Tetrafluoropropene And 3,3,3-Trifluoropropene |
| JP2012508778A (ja) * | 2008-11-13 | 2012-04-12 | ゾルファイ フルーオル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ヒドロフルオロオレフィン、ヒドロフルオロオレフィンの製造およびヒドロフルオロオレフィンを用いる方法 |
| GB2456028A (en) * | 2008-11-14 | 2009-07-01 | Consort Medical Plc | A medicament dispenser with an HFO propellant |
| US20100122545A1 (en) | 2008-11-19 | 2010-05-20 | E. I. Du Pont De Nemours And Company | Tetrafluoropropene compositions and uses thereof |
| US8871112B2 (en) * | 2008-11-19 | 2014-10-28 | E I Du Pont De Nemours And Company | Compositions comprising 2,3,3,3-tetrafluoropropene and hydrocarbons and uses thereof |
| CN102292469A (zh) | 2009-01-22 | 2011-12-21 | 阿科玛股份有限公司 | 具有受抑制的或者提高的闪点的反式-1,2-二氯乙烯与1-氯-3,3,3-三氟丙烯组合物 |
| EP2391691A4 (de) * | 2009-01-29 | 2013-09-18 | Arkema Inc | Blähmittelzusammensetzungen auf basis von tetrafluorpropen |
| JP5502410B2 (ja) * | 2009-01-30 | 2014-05-28 | パナソニック株式会社 | 液体循環式暖房システム |
| JP5242434B2 (ja) * | 2009-01-30 | 2013-07-24 | パナソニック株式会社 | 液体循環式暖房システム |
| JP5401642B2 (ja) | 2009-03-27 | 2014-01-29 | サンデン株式会社 | 冷凍回路形成部材 |
| JP2010242696A (ja) * | 2009-04-09 | 2010-10-28 | Panasonic Corp | ロータリ圧縮機 |
| GB0906547D0 (en) * | 2009-04-16 | 2009-05-20 | Ineos Fluor Holdings Ltd | Heat transfer compositions |
| US20110147638A1 (en) * | 2009-06-26 | 2011-06-23 | E.I. Du Pont De Nemours And Company | Azeotropic and azeotrope-like compositions of z-1,1,1,4,4,4-hexafluoro-2-butene, trans-1,2-dichloroethylene, and cyclopentane |
| FR2948678B1 (fr) | 2009-07-28 | 2011-10-14 | Arkema France | Procede de transfert de chaleur |
| FR2948679B1 (fr) | 2009-07-28 | 2011-08-19 | Arkema France | Procede de transfert de chaleur |
| WO2011019350A1 (en) | 2009-08-13 | 2011-02-17 | Arkema Inc. | Azeotrope and azeotrope-like composition of 1-chloro-3,3,3-trifluoropropene and hcfc-123 |
| EP2471896B1 (de) | 2009-08-28 | 2017-05-24 | JX Nippon Oil & Energy Corporation | Kühlöl für gefriergeräte und betriebsflüssigkeitszusammensetzung für gefriergeräte |
| EP4219645A1 (de) | 2009-09-09 | 2023-08-02 | Honeywell International, Inc. | Monochlortrifluorpropenverbindungen sowie zusammensetzungen und verfahren damit |
| FR2950066B1 (fr) | 2009-09-11 | 2011-10-28 | Arkema France | Refrigeration basse et moyenne temperature |
| FR2950065B1 (fr) | 2009-09-11 | 2012-02-03 | Arkema France | Fluide refrigerant binaire |
| FR2950069B1 (fr) | 2009-09-11 | 2011-11-25 | Arkema France | Utilisation de compositions ternaires |
| FR2950068B1 (fr) | 2009-09-11 | 2012-05-18 | Arkema France | Procede de transfert de chaleur |
| FR2950067B1 (fr) | 2009-09-11 | 2011-10-28 | Arkema France | Fluide de transfert de chaleur en remplacement du r-410a |
| FR2950071B1 (fr) | 2009-09-11 | 2012-02-03 | Arkema France | Compositions ternaires pour refrigeration basse capacite |
| US10035938B2 (en) | 2009-09-11 | 2018-07-31 | Arkema France | Heat transfer fluid replacing R-134a |
| FR2950070B1 (fr) | 2009-09-11 | 2011-10-28 | Arkema France | Compositions ternaires pour refrigeration haute capacite |
| JP2011064409A (ja) * | 2009-09-17 | 2011-03-31 | Sanden Corp | 受液器およびそれを備えた冷凍回路 |
| EP2488343A1 (de) | 2009-10-16 | 2012-08-22 | Dow Global Technologies LLC | Verbessertes verfahren zur herstellung eines formschaumstoffartikels |
| US20120216551A1 (en) * | 2009-11-03 | 2012-08-30 | E.I. Du Pont De Nemours And Company | Cascade refrigeration system with fluoroolefin refrigerant |
| CN102762350A (zh) | 2009-11-24 | 2012-10-31 | 陶氏环球技术有限责任公司 | 用于形成双面成型泡沫制品的方法 |
| FR2954342B1 (fr) | 2009-12-18 | 2012-03-16 | Arkema France | Fluides de transfert de chaleur a inflammabilite reduite |
| ES2762350T3 (es) | 2009-12-22 | 2020-05-22 | Chemours Co Fc Llc | Composiciones que comprenden 2,3,3,3-tetrafluoropropeno y 2,3-dicloro-3,3-difluoropropeno |
| GB201002622D0 (en) | 2010-02-16 | 2010-03-31 | Ineos Fluor Holdings Ltd | Heat transfer compositions |
| FR2957083B1 (fr) | 2010-03-02 | 2015-12-11 | Arkema France | Fluide de transfert de chaleur pour compresseur centrifuge |
| JP5466556B2 (ja) | 2010-03-25 | 2014-04-09 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| JP5466555B2 (ja) | 2010-03-25 | 2014-04-09 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| US8821749B2 (en) | 2010-04-26 | 2014-09-02 | E I Du Pont De Nemours And Company | Azeotrope-like compositions of E-1,1,1,4,4,4-hexafluoro-2-butene and 1-chloro-3,3,3-trifluoropropene |
| FR2959997B1 (fr) | 2010-05-11 | 2012-06-08 | Arkema France | Fluides de transfert de chaleur et leur utilisation dans des echangeurs de chaleur a contre-courant |
| FR2959998B1 (fr) | 2010-05-11 | 2012-06-01 | Arkema France | Fluides de transfert de chaleur ternaires comprenant du difluoromethane, du pentafluoroethane et du tetrafluoropropene |
| FR2959999B1 (fr) | 2010-05-11 | 2012-07-20 | Arkema France | Fluides de transfert de chaleur et leur utilisation dans des echangeurs de chaleur a contre-courant |
| WO2011144908A2 (en) | 2010-05-20 | 2011-11-24 | Mexichem Amanco Holding S.A. De C.V. | Heat transfer compositions |
| GB2480513B (en) * | 2010-05-20 | 2013-01-02 | Mexichem Amanco Holding Sa | Heat transfer compositions |
| WO2011163160A1 (en) | 2010-06-23 | 2011-12-29 | Dow Global Technologies Llc | Method for stamping a shaped foam article |
| GB2481443B (en) | 2010-06-25 | 2012-10-17 | Mexichem Amanco Holding Sa | Heat transfer compositions |
| FR2962130B1 (fr) | 2010-06-30 | 2012-07-20 | Arkema France | Composition a base de 2,3,3,3-tetrafluoropropene |
| FR2962442B1 (fr) * | 2010-07-09 | 2016-02-26 | Arkema France | Composition stable de 2,3,3,3-tetrafluoropropene |
| FR2964977B1 (fr) | 2010-09-20 | 2013-11-01 | Arkema France | Composition a base de 3,3,3-tetrafluoropropene |
| FR2964976B1 (fr) | 2010-09-20 | 2012-08-24 | Arkema France | Composition a base de 1,3,3,3-tetrafluoropropene |
| FR2964975B1 (fr) | 2010-09-20 | 2012-08-24 | Arkema France | Composition a base de 2,3,3,3-tetrafluoropropene |
| EP2630107B1 (de) * | 2010-10-22 | 2020-01-08 | Arkema France | Verfahren zur herstellung von 2-chloro-3,3,3-trifluorpropen mittels gasphasenfluorierung von pentachloropropan |
| US8734671B2 (en) | 2010-11-19 | 2014-05-27 | Honeywell International Inc. | Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene |
| US8889031B2 (en) | 2010-11-30 | 2014-11-18 | Jx Nippon Oil & Energy Corporation | Working fluid composition for refrigerator machine and refrigerating machine oil |
| FR2971512B1 (fr) | 2011-02-10 | 2013-01-18 | Arkema France | Compositions binaires de 2,3,3,3-tetrafluoropropene et d'ammoniac |
| FR2973717B1 (fr) | 2011-04-08 | 2013-03-29 | Ceca Sa | Procede de reduction de l'acidite totale de compositions frigorigenes |
| FR2973809B1 (fr) | 2011-04-08 | 2015-11-13 | Ceca Sa | Utilisation de zeolithes pour la stabilisation d'huiles |
| JP5921818B2 (ja) * | 2011-04-27 | 2016-05-24 | 東洋エアゾール工業株式会社 | エアゾール組成物 |
| FR2974812B1 (fr) | 2011-05-04 | 2014-08-08 | Arkema France | Compositions de transfert de chaleur presentant une miscibilite amelioree avec l'huile de lubrification |
| JP5870246B2 (ja) * | 2011-05-10 | 2016-02-24 | パナソニックIpマネジメント株式会社 | ロータリ圧縮機 |
| CN103547652B (zh) | 2011-05-19 | 2016-06-29 | 旭硝子株式会社 | 工作介质及热循环系统 |
| EP3854860A1 (de) | 2011-05-19 | 2021-07-28 | Agc Inc. | Arbeitsmedium und wärmezyklussystem |
| FR2977256B1 (fr) * | 2011-07-01 | 2013-06-21 | Arkema France | Compositions de 2,4,4,4-tetrafluorobut-1-ene et de cis-1,1,1,4,4,4-hexafluorobut-2-ene |
| US9169427B2 (en) * | 2011-07-13 | 2015-10-27 | Honeywell International Inc. | Low GWP heat transfer compositions containing difluoromethane, a fluorinated ethane and 1,3,3,3-tetrafluoropropene |
| EP2772526A4 (de) | 2011-10-26 | 2015-04-29 | Jx Nippon Oil & Energy Corp | Arbeitsflüssigkeitszusammensetzung und kühlöl für kältemaschine |
| CA3085086C (en) | 2011-12-06 | 2023-08-08 | Delta Faucet Company | Ozone distribution in a faucet |
| WO2013086264A1 (en) * | 2011-12-09 | 2013-06-13 | E. I. Du Pont De Nemours And Company | Composition comprising fluoroalkyl perfluoroalkene ethers and uses thereof |
| FR2986007B1 (fr) | 2012-01-25 | 2015-01-23 | Arkema France | Compositions de transfert de chaleur presentant une miscibilite amelioree avec l'huile de lubrification |
| FR2986236B1 (fr) | 2012-01-26 | 2014-01-10 | Arkema France | Compositions de transfert de chaleur presentant une miscibilite amelioree avec l'huile de lubrification |
| JP5914066B2 (ja) | 2012-03-12 | 2016-05-11 | 出光興産株式会社 | 冷凍機用潤滑油組成物 |
| US10144855B2 (en) | 2012-03-27 | 2018-12-04 | Jxtg Nippon Oil And Energy Corporation | Working fluid composition for refrigerator |
| JP5977817B2 (ja) | 2012-03-29 | 2016-08-24 | Jxエネルギー株式会社 | 冷凍機用作動流体組成物 |
| JP5871688B2 (ja) | 2012-03-29 | 2016-03-01 | Jx日鉱日石エネルギー株式会社 | 冷凍機用作動流体組成物 |
| JP5937446B2 (ja) | 2012-07-13 | 2016-06-22 | Jxエネルギー株式会社 | 冷凍機用作動流体組成物 |
| FR2998302B1 (fr) | 2012-11-20 | 2015-01-23 | Arkema France | Composition refrigerante |
| US8940180B2 (en) * | 2012-11-21 | 2015-01-27 | Honeywell International Inc. | Low GWP heat transfer compositions |
| JP5946755B2 (ja) * | 2012-12-07 | 2016-07-06 | Jxエネルギー株式会社 | 冷凍機油組成物および冷凍機用作動流体組成物 |
| JP6010492B2 (ja) | 2013-03-15 | 2016-10-19 | 出光興産株式会社 | 冷凍機油組成物及び冷凍機システム |
| FR3003566B1 (fr) | 2013-03-20 | 2018-07-06 | Arkema France | Composition comprenant hf et e-3,3,3-trifluoro-1-chloropropene |
| CN103232645A (zh) * | 2013-04-26 | 2013-08-07 | 中塑联新材料科技湖北有限公司 | 聚苯乙烯密度调节剂 |
| FR3008419B1 (fr) | 2013-07-11 | 2015-07-17 | Arkema France | Compositions a base de 2,3,3,3-tetrafluoropropene presentant une miscibilite amelioree |
| FR3010415B1 (fr) | 2013-09-11 | 2015-08-21 | Arkema France | Fluides de transfert de chaleur comprenant du difluoromethane, du pentafluoroethane, du tetrafluoropropene et eventuellement du propane |
| MX2016003162A (es) | 2013-09-19 | 2016-07-05 | Dow Global Technologies Llc | Proceso asistido con vacio para producir espumas rigidas de poliuretano de celula cerrada utilizando agentes de soplado mixtos. |
| GB201318244D0 (en) * | 2013-10-15 | 2013-11-27 | Rpl Holdings Ltd | Refrigerant |
| JP6381890B2 (ja) | 2013-10-25 | 2018-08-29 | 三菱重工サーマルシステムズ株式会社 | 冷媒循環装置、冷媒循環方法および異性化抑制方法 |
| JP6138957B2 (ja) | 2013-10-25 | 2017-05-31 | 三菱重工業株式会社 | 冷媒循環装置、冷媒循環方法および酸抑制方法 |
| JP6773326B2 (ja) | 2013-12-20 | 2020-10-21 | スリーエム イノベイティブ プロパティズ カンパニー | 作動流体としてのフッ素化オレフィン及びその使用方法 |
| WO2015109095A1 (en) | 2014-01-16 | 2015-07-23 | Shrieve Chemical Products, Inc. | Desicating synthetic refrigeration lubricant composition |
| WO2015129548A1 (ja) | 2014-02-28 | 2015-09-03 | 旭硝子株式会社 | 熱サイクル用作動媒体、熱サイクルシステム用組成物および熱サイクルシステム |
| US10144175B2 (en) * | 2014-03-18 | 2018-12-04 | Evolve Additive Solutions, Inc. | Electrophotography-based additive manufacturing with solvent-assisted planarization |
| GB201410174D0 (en) | 2014-06-09 | 2014-07-23 | Mexichem Amanco Holding Sa | Process |
| US10330364B2 (en) | 2014-06-26 | 2019-06-25 | Hudson Technologies, Inc. | System and method for retrofitting a refrigeration system from HCFC to HFC refrigerant |
| JP5767370B2 (ja) * | 2014-06-27 | 2015-08-19 | Jx日鉱日石エネルギー株式会社 | 冷凍機油及び冷凍機用作動流体組成物 |
| CN106661438A (zh) | 2014-09-26 | 2017-05-10 | 大金工业株式会社 | 卤代烯类组合物及其使用 |
| JP2016069634A (ja) | 2014-09-26 | 2016-05-09 | ダイキン工業株式会社 | ハロオレフィン類組成物 |
| FR3033791B1 (fr) | 2015-03-18 | 2017-04-14 | Arkema France | Stabilisation du 1-chloro-3,3,3-trifluoropropene |
| KR101581783B1 (ko) * | 2015-04-02 | 2016-01-04 | 서울대학교 산학협력단 | 나노유체 채널을 기반으로 하는 채널 구조물 및 이를 제조하는 방법 |
| CA3007437C (en) | 2015-12-21 | 2021-09-28 | Delta Faucet Company | Fluid delivery system including a disinfectant device |
| JP6069547B2 (ja) * | 2016-01-22 | 2017-02-01 | 東洋エアゾール工業株式会社 | エアゾール組成物 |
| FR3056222B1 (fr) | 2016-09-19 | 2020-01-10 | Arkema France | Composition a base de 1-chloro-3,3,3-trifluoropropene |
| FR3057272B1 (fr) | 2016-10-10 | 2020-05-08 | Arkema France | Compositions azeotropiques a base de tetrafluoropropene |
| FR3057271B1 (fr) | 2016-10-10 | 2020-01-17 | Arkema France | Utilisation de compositions a base de tetrafluoropropene |
| FR3061905B1 (fr) | 2017-01-19 | 2019-05-17 | Arkema France | Composition comprenant du 2,3,3,3-tetrafluoropropene |
| FR3061906B1 (fr) | 2017-01-19 | 2019-03-15 | Arkema France | Composition comprenant du 2,3,3,3-tetrafluoropropene |
| JP6897119B2 (ja) | 2017-01-30 | 2021-06-30 | ダイキン工業株式会社 | 冷凍装置 |
| JP2018123691A (ja) | 2017-01-30 | 2018-08-09 | ダイキン工業株式会社 | 圧縮機 |
| JP2018123970A (ja) | 2017-01-30 | 2018-08-09 | ダイキン工業株式会社 | 冷凍装置 |
| FR3063733B1 (fr) | 2017-03-10 | 2020-02-07 | Arkema France | Composition quasi-azeotropique comprenant le 2,3,3,3-tetrafluoropropene et le trans-1,3,3,3-tetrafluoropropene |
| FR3064264B1 (fr) | 2017-03-21 | 2019-04-05 | Arkema France | Composition a base de tetrafluoropropene |
| FR3064275B1 (fr) | 2017-03-21 | 2019-06-07 | Arkema France | Procede de chauffage et/ou climatisation d'un vehicule |
| JP6598815B2 (ja) * | 2017-05-24 | 2019-10-30 | 株式会社大一商会 | 遊技機 |
| JP6598217B2 (ja) * | 2017-05-24 | 2019-10-30 | 株式会社大一商会 | 遊技機 |
| JP6591494B2 (ja) * | 2017-05-24 | 2019-10-16 | 株式会社大一商会 | 遊技機 |
| CN107353625A (zh) * | 2017-07-14 | 2017-11-17 | 成都三乙医疗科技有限公司 | 热疗用石蜡保温材料及其加工方法 |
| FR3070982B1 (fr) | 2017-09-12 | 2019-08-30 | Arkema France | Composition a base d'hydrochlorofluoroolefine et d'huile minerale |
| JP7084046B2 (ja) * | 2017-10-25 | 2022-06-14 | 神戸合成株式会社 | 洗浄剤組成物及びそのエアゾール組成物 |
| CN116179163A (zh) * | 2017-11-30 | 2023-05-30 | 霍尼韦尔国际公司 | 热传递组合物、方法和系统 |
| FR3077822B1 (fr) | 2018-02-15 | 2020-07-24 | Arkema France | Compositions de transfert de chaleur en remplacement du r-134a |
| EP3744808B1 (de) * | 2018-02-20 | 2022-03-30 | PHC Holdings Corporation | Kältespeichervorrichtung |
| EP4357444A3 (de) | 2018-04-30 | 2024-07-03 | The Chemours Company FC, LLC | Stabilisierte fluorolefinzusammensetzungen und verfahren zu ihrer herstellung, lagerung und verwendung |
| US10647645B2 (en) * | 2018-10-15 | 2020-05-12 | Honeywell International Inc. | Azeotrope or azeotrope-like compositions of trifluoroiodomethane (CF3I) and 1,1,3,3,3,-pentafluoropropene (HFO-1225zc) |
| US11209196B2 (en) | 2018-10-26 | 2021-12-28 | The Chemours Company Fc, Llc | HFO-1234ZE, HFO-1225ZC and HFO-1234YF compositions and processes for producing and using the compositions |
| BR112021022059A2 (pt) | 2018-10-26 | 2021-12-28 | Chemours Co Fc Llc | Composições de fluoropropeno, métodos de produção de uma mistura e de resfriamento, processos para transferência de calor, para tratamento de uma superfície e para formação de uma composição, sistema de refrigeração, aparelhos de refrigeração, uso da composição de fluoropropeno e método para substituição de um refrigerante |
| KR20250171450A (ko) | 2018-10-26 | 2025-12-08 | 더 케무어스 컴퍼니 에프씨, 엘엘씨 | Hfo-1234ze 및 hfo-1234yf 조성물, 및 조성물의 제조 및 사용 방법 |
| ES2980486T3 (es) * | 2019-03-04 | 2024-10-01 | Chemours Co Fc Llc | Composiciones de transferencia de calor que comprenden R-1225ye(e) |
| JP7490385B2 (ja) | 2020-02-19 | 2024-05-27 | 出光興産株式会社 | 冷凍機油組成物及び冷凍機用混合組成物 |
| US11499122B2 (en) | 2020-02-27 | 2022-11-15 | The Boeing Company | Methods for degreasing surfaces |
| CN114907816A (zh) * | 2021-02-07 | 2022-08-16 | 浙江省化工研究院有限公司 | 一种替代HFC-245fa的传热组合物 |
| JPWO2022196689A1 (de) | 2021-03-16 | 2022-09-22 | ||
| JP7710871B2 (ja) | 2021-03-31 | 2025-07-22 | 出光興産株式会社 | 冷凍機油組成物及び冷凍機用混合組成物 |
| PT4175619T (pt) | 2021-07-09 | 2024-06-06 | AstraZeneca Pharmaceuticals LP | Composições, métodos e sistemas para administração de fármacos em aerossol |
| CN117916338A (zh) * | 2021-09-08 | 2024-04-19 | 科慕埃弗西有限公司 | 包含四氟丙烯、四氟乙烷和五氟丙烯的组合物及其用途 |
| US11753516B2 (en) | 2021-10-08 | 2023-09-12 | Covestro Llc | HFO-containing compositions and methods of producing foams |
| US20230190598A1 (en) * | 2021-12-16 | 2023-06-22 | Honeywell International Inc. | Hairspray formulations for hfo propellants |
| EP4481021A1 (de) | 2022-02-15 | 2024-12-25 | Idemitsu Kosan Co.,Ltd. | Kühlschrankölzusammensetzung und mischzusammensetzung für kühlschrank |
| CN116854559B (zh) * | 2023-07-06 | 2024-05-31 | 亚培烯科技(上海)有限公司 | 部分氟化合成烃及其制备方法和应用 |
Family Cites Families (116)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2785984A (en) * | 1953-06-30 | 1957-03-19 | Dow Chemical Co | Fumigation with chlorofluoropropenes |
| BE536296A (de) * | 1954-03-22 | |||
| IT535373A (de) | 1954-06-10 | |||
| US2869379A (en) | 1954-08-04 | 1959-01-20 | Chain Belt Co | Chain sideplate construction |
| US2917460A (en) | 1955-06-17 | 1959-12-15 | Ibm | Powder compositions useful as electroscopic toners |
| US2834848A (en) | 1955-09-02 | 1958-05-13 | Bell Telephone Labor Inc | Electric switch |
| US2846458A (en) | 1956-05-23 | 1958-08-05 | Dow Corning | Organosiloxane ethers |
| US2889379A (en) | 1957-02-06 | 1959-06-02 | Dow Chemical Co | Preparation of 3, 3, 3-trifluoropropene |
| US2925446A (en) * | 1958-06-16 | 1960-02-16 | Du Pont | Fluorinated internal olefins and their preparation |
| NL121693C (de) | 1959-05-22 | |||
| DE1122697B (de) * | 1960-05-06 | 1962-01-25 | Bayer Ag | Verfahren zur Herstellung von Schaumstoffen auf Isocyanatbasis |
| US3884828A (en) * | 1970-10-15 | 1975-05-20 | Dow Corning | Propellants and refrigerants based on trifluoropropene |
| US3723318A (en) * | 1971-11-26 | 1973-03-27 | Dow Corning | Propellants and refrigerants based on trifluoropropene |
| FR2280360A1 (fr) * | 1974-08-02 | 1976-02-27 | Sogeras | Composition cosmetologique oxygenante |
| FR2521240B1 (fr) | 1982-02-05 | 1987-03-27 | Valeo | Garniture de friction notamment pour freins, embrayages et autres applications |
| US4465788A (en) | 1982-09-10 | 1984-08-14 | Chevron Research Company | Olefin oligomerization with an activated catalyst |
| US4465786A (en) | 1982-09-27 | 1984-08-14 | General Electric Company | Catalyst composition for the preparation of 3,3,3-trifluoropropene |
| US4788352A (en) | 1986-07-21 | 1988-11-29 | Shell Oil Company | Trifluoroalkenes and a method for their preparation |
| JPH0688920B2 (ja) * | 1987-02-27 | 1994-11-09 | ダイキン工業株式会社 | 2,3,3,3−テトラフルオロプロペンの製法 |
| US4796818A (en) | 1987-07-30 | 1989-01-10 | Beloit Corporation | Chip slicer improvement |
| US4798818A (en) | 1987-11-27 | 1989-01-17 | Dow Corning Corporation | Catalyst composition and process for its preparation |
| US5776434A (en) * | 1988-12-06 | 1998-07-07 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| US5001287A (en) * | 1989-02-02 | 1991-03-19 | E. I. Du Pont De Nemours And Company | Purification of saturated halocarbons |
| EP0382095B1 (de) * | 1989-02-06 | 1995-05-10 | Asahi Glass Company Ltd. | Azeotrope oder azeotropähnliche Zusammensetzung auf der Basis von Wasserstoff enthaltenden Chlorfluorkohlenwasserstoffen |
| JPH02222496A (ja) * | 1989-02-23 | 1990-09-05 | Asahi Glass Co Ltd | ドライクリーニング用洗浄剤 |
| JPH02221388A (ja) | 1989-02-23 | 1990-09-04 | Asahi Glass Co Ltd | 脱脂洗浄剤 |
| JPH02222497A (ja) * | 1989-02-23 | 1990-09-05 | Asahi Glass Co Ltd | フラックス洗浄剤 |
| JPH02222469A (ja) * | 1989-02-23 | 1990-09-05 | Asahi Glass Co Ltd | レジスト剥離剤 |
| US5269955A (en) | 1989-05-08 | 1993-12-14 | Idemitsu Kosan Co., Ltd. | Lubricating oil for compression-type refrigerators and polyoxyalkylene glycol derivative |
| US4945119A (en) | 1989-05-10 | 1990-07-31 | The Dow Chemical Company | Foaming system for rigid urethane and isocyanurate foams |
| US4944890A (en) | 1989-05-23 | 1990-07-31 | E. I. Du Pont De Nemours And Company | Compositions and process of using in refrigeration |
| JP2751428B2 (ja) * | 1989-06-30 | 1998-05-18 | 旭硝子株式会社 | 3,3―ジクロロ―1,1,1,2,2―ペンタフルオロプロパン系組成物 |
| AU6735490A (en) * | 1989-10-16 | 1991-05-16 | E.I. Du Pont De Nemours And Company | Process for chlorofluoropropanes |
| US4994890A (en) * | 1989-11-27 | 1991-02-19 | Snap-On Tools Corporation | Rectifier structure with individual links |
| US5053155A (en) * | 1989-12-19 | 1991-10-01 | E. I. Du Pont De Nemours And Company | Compositions and process for use in refrigeration |
| FR2658532B1 (fr) | 1990-02-20 | 1992-05-15 | Atochem | Application des (perfluoroalkyl)-ethylenes comme agents de nettoyage ou de sechage, et compositions utilisables a cet effet. |
| JPH04109897A (ja) * | 1990-08-29 | 1992-04-10 | Hitachi Ltd | 電動機の運転装置 |
| JPH04110388A (ja) * | 1990-08-31 | 1992-04-10 | Daikin Ind Ltd | 熱伝達用流体 |
| US5118360A (en) | 1990-12-04 | 1992-06-02 | Allied-Signal Inc. | Method of cleaning using partially fluorinated alkenes having a tertiary structure as solvent |
| US5158617A (en) | 1991-04-18 | 1992-10-27 | Allied-Signal Inc. | Method of cleaning using hydrochlorofluorocarbons having 3 to 5 carbon atoms |
| DE4121161A1 (de) * | 1991-06-27 | 1993-01-07 | Basf Ag | Verfahren zur herstellung von urethan- oder urethan- und isocyanuratgruppen enthaltenden hartschaumstoffen und treibmittel enthaltende emulsionen hierfuer |
| JPH0542230A (ja) * | 1991-08-13 | 1993-02-23 | Daikin Ind Ltd | 消火剤 |
| JPH0585970A (ja) | 1991-09-25 | 1993-04-06 | Daikin Ind Ltd | 冷 媒 |
| US5264044A (en) | 1991-09-27 | 1993-11-23 | Alliedsignal Inc. | Method of cleaning using hydrochlorofluorocarbons having a tertiary structure |
| JPH05179045A (ja) * | 1991-11-18 | 1993-07-20 | Daikin Ind Ltd | フルオロブテンからなる発泡剤およびプラスチック発泡体の製造方法 |
| JPH05179043A (ja) * | 1991-11-18 | 1993-07-20 | Daikin Ind Ltd | フルオロブテンからなる発泡剤およびプラスチック発泡体の製造方法 |
| JPH05179042A (ja) * | 1991-11-18 | 1993-07-20 | Daikin Ind Ltd | フルオロプロペンからなる発泡剤およびプラスチック発泡体の製造方法 |
| US5250208A (en) * | 1992-04-02 | 1993-10-05 | E. I. Du Pont De Nemours And Company | Ternary azeotropic compositions |
| US5679875A (en) * | 1992-06-05 | 1997-10-21 | Daikin Industries, Ltd. | Method for manufacturing 1,1,1,2,3-pentafluoropropene 1,1,1,2,3-pentafluoropropane |
| DE69315637T2 (de) * | 1992-08-05 | 1998-06-10 | Nippon Oil Co Ltd | Fältemaschinenölzusammensetzung für Fluoroalkanekühlmittel |
| JP3369604B2 (ja) | 1992-09-04 | 2003-01-20 | ダイキン工業株式会社 | 1,1,1,2,3,3−ヘキサフルオロプロパンの製造方法及びテトラフルオロクロロプロペンの製造方法 |
| CN1119454A (zh) * | 1993-02-05 | 1996-03-27 | 纳幕尔杜邦公司 | 含氟烃和烃的混合物 |
| GB2276392B (en) | 1993-02-22 | 1997-03-26 | D G P | Improved production of natural flavours and fragrances |
| US5611210A (en) | 1993-03-05 | 1997-03-18 | Ikon Corporation | Fluoroiodocarbon blends as CFC and halon replacements |
| US5538659A (en) * | 1993-03-29 | 1996-07-23 | E. I. Du Pont De Nemours And Company | Refrigerant compositions including hexafluoropropane and a hydrofluorocarbon |
| US5494601A (en) | 1993-04-01 | 1996-02-27 | Minnesota Mining And Manufacturing Company | Azeotropic compositions |
| US5396000A (en) * | 1993-05-24 | 1995-03-07 | E. I. Du Pont De Nemours And Company | Process for the manufacture of 1,1,1,2,3,-pentafluoropropane |
| US5449041A (en) * | 1993-06-24 | 1995-09-12 | Olin Corporation | Apparatus and method for suppressing a fire |
| US5370812A (en) * | 1993-06-28 | 1994-12-06 | Union Carbide Chemicals & Plastics Technology Corporation | Lubricant compositions for refrigerators comprising polyalkylene glycol and a hydrocarbon solvent |
| US5578137A (en) * | 1993-08-31 | 1996-11-26 | E. I. Du Pont De Nemours And Company | Azeotropic or azeotrope-like compositions including 1,1,1,2,3,4,4,5,5,5-decafluoropentane |
| US5318996A (en) * | 1993-10-08 | 1994-06-07 | Basf Corporation | Rigid insulating polyurethane foams prepared from ternary blowing agent mixtures |
| CN1064070C (zh) * | 1994-03-15 | 2001-04-04 | 东芝株式会社 | 充填入氢氟碳系冷冻循环组合物的干燥剂 |
| US5446217A (en) | 1994-05-16 | 1995-08-29 | Alliedsignal Inc. | Processes for the preparation of fluorinated olefins and hydrofluorocarbons using fluorinated olefin |
| DE69505982T2 (de) * | 1994-07-11 | 1999-06-17 | Solvay Fluor Und Derivate Gmbh, 30173 Hannover | Kältemittel |
| KR0180613B1 (en) * | 1994-09-07 | 1999-05-15 | Matsushita Electric Industrial Co Ltd | Thermal insulating foamed material and method for manufacturing the same |
| JPH08157847A (ja) * | 1994-12-08 | 1996-06-18 | Japan Energy Corp | Hfcフロン圧縮機用潤滑油組成物、hfcフロン圧縮機の潤滑性向上方法及び同潤滑油組成物を含有する作動流体組成物 |
| RU2073058C1 (ru) | 1994-12-26 | 1997-02-10 | Олег Николаевич Подчерняев | Озонобезопасная рабочая смесь |
| KR100188298B1 (ko) * | 1995-01-30 | 1999-06-01 | 모리시따요오이찌 | 단열발포체 및 그 제조방법 |
| US5714083A (en) * | 1995-01-30 | 1998-02-03 | Turner; Donald E. | A non-flammable refrigerant fluid containing hexa fluoropropane and hydrocarbons |
| FR2731436B1 (fr) | 1995-03-09 | 1997-04-30 | Atochem Elf Sa | Utilisation d'hydrofluoroalcenes comme agents de nettoyage, et compositions utilisables a cet effet |
| US5520208A (en) * | 1995-04-03 | 1996-05-28 | Accumulators, Inc. | Resilient seal for a liquid-gas accumulator |
| KR100427737B1 (ko) * | 1995-05-16 | 2004-07-31 | 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 | 공비혼합물형조성물및그의용도 |
| AU6862896A (en) * | 1995-08-25 | 1997-03-19 | Dwight D. Back | Fire extinguishing methods and blends utilizing unsaturated perfluorocarbons |
| EP0779351B1 (de) * | 1995-12-14 | 2002-07-10 | AUSIMONT S.p.A. | Pseudo-azeotrope Mischungen von Hydrofluorcarbonen und Hydrocarbonen zur Verwendung als Treibmittel für Aerosol |
| FR2748473B1 (fr) * | 1996-05-13 | 1998-07-24 | Atochem Elf Sa | Synthese du 1-chloro-3,3,3 trifluoropropene et sa fluoration en 1,1,1,3,3 pentafluoropropane |
| JP3465865B2 (ja) * | 1996-06-20 | 2003-11-10 | セントラル硝子株式会社 | 1,3,3,3−テトラフルオロプロペンの製造法 |
| US6111150A (en) * | 1996-06-20 | 2000-08-29 | Central Glass Company, Limited | Method for producing 1,1,1,3,3,-pentafluoropropane |
| IL128302A0 (en) | 1996-08-08 | 1999-11-30 | Donald E Turner | Alternative refrigerant including hexafluoropropylene |
| JPH10139697A (ja) † | 1996-09-09 | 1998-05-26 | Asahi Glass Co Ltd | 含フッ素炭化水素系組成物 |
| MY115694A (en) * | 1996-09-09 | 2003-08-30 | Asahi Glass Co Ltd | Fluorine- containing hydrocarbon composition |
| US5710352A (en) * | 1996-09-19 | 1998-01-20 | Alliedsignal Inc. | Vapor phase process for making 1,1,1,3,3-pentafluoropropane and 1-chloro-3,3,3-trifluoropropene |
| US6300378B1 (en) * | 1996-09-27 | 2001-10-09 | University Of New Mexico | Tropodegradable bromine-containing halocarbon additives to decrease flammability of refrigerants foam blowing agents solvents aerosol propellants and sterilants |
| US5900185A (en) * | 1996-09-27 | 1999-05-04 | University Of New Mexico | Tropodegradable bromine-containing halocarbon additives to decrease flammability of refrigerants, foam blowing agents, solvents, aerosol propellants, and sterilants |
| JP3895413B2 (ja) * | 1996-11-30 | 2007-03-22 | 株式会社テクノ大西 | 冷凍機用冷媒圧縮装置 |
| US6376727B1 (en) * | 1997-06-16 | 2002-04-23 | E. I. Du Pont De Nemours And Company | Processes for the manufacture of 1,1,1,3,3-pentafluoropropene, 2-chloro-pentafluoropropene and compositions comprising saturated derivatives thereof |
| US5788886A (en) * | 1997-05-05 | 1998-08-04 | E. I. Du Pont De Nemours And Company | Pentafluoropropane compositions |
| US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
| US6031011A (en) * | 1997-06-25 | 2000-02-29 | University Of New Mexico | Tropodegradable bromine-containing halocarbons as foam blowing agents |
| US5811603A (en) * | 1997-12-01 | 1998-09-22 | Elf Atochem North America, Inc. | Gas phase fluorination of 1230za |
| US5856595A (en) * | 1998-03-03 | 1999-01-05 | Alliedsignal Inc. | Purified 1,1,1,3,3,3-hexafluoropropane and method for making same |
| DE19816810C2 (de) | 1998-04-16 | 2000-06-08 | Preh Elektro Feinmechanik | Kapazitiver Winkelsensor |
| US6274543B1 (en) * | 1998-06-05 | 2001-08-14 | 3M Innovative Properties Company | Cleaning and coating composition and methods of using same |
| JP4153590B2 (ja) * | 1998-06-26 | 2008-09-24 | 株式会社三愛 | 作動流体 |
| US6124510A (en) * | 1998-07-21 | 2000-09-26 | Elf Atochem North America, Inc. | 1234ze preparation |
| JP3804289B2 (ja) * | 1998-09-22 | 2006-08-02 | ダイキン工業株式会社 | 1,1,1,3,3−ペンタフルオロプロパン及び/又は1−クロロ−3,3,3−トリフルオロプロペンの製造方法 |
| US6881354B2 (en) * | 1998-12-30 | 2005-04-19 | Praxair Technology, Inc. | Multicomponent refrigerant fluids for low and cryogenic temperatures |
| US6176102B1 (en) * | 1998-12-30 | 2001-01-23 | Praxair Technology, Inc. | Method for providing refrigeration |
| US6041621A (en) * | 1998-12-30 | 2000-03-28 | Praxair Technology, Inc. | Single circuit cryogenic liquefaction of industrial gas |
| US6327866B1 (en) * | 1998-12-30 | 2001-12-11 | Praxair Technology, Inc. | Food freezing method using a multicomponent refrigerant |
| GB9901667D0 (en) * | 1999-01-26 | 1999-03-17 | Ici Plc | Lubricant composition |
| JP4316044B2 (ja) * | 1999-04-01 | 2009-08-19 | 出光興産株式会社 | 冷凍機油組成物 |
| US6583328B1 (en) * | 1999-04-05 | 2003-06-24 | Pcbu Services, Inc. | Method for the preparation of 1,1,1,3,3-pentafluoropropene and 1,1,1,3,3-pentafluoropropane |
| US6589355B1 (en) * | 1999-10-29 | 2003-07-08 | Alliedsignal Inc. | Cleaning processes using hydrofluorocarbon and/or hydrochlorofluorocarbon compounds |
| JP2002016204A (ja) * | 2000-06-28 | 2002-01-18 | Ts Heatronics Co Ltd | 受放熱構造体 |
| JP4046932B2 (ja) * | 2000-07-13 | 2008-02-13 | 株式会社日立製作所 | 冷蔵庫用作動媒体および冷蔵庫 |
| US6294107B1 (en) * | 2000-07-26 | 2001-09-25 | Basf Corporation | Alkylene oxide modified silicone glycol compatibilizing agents for stable polyester polyol compositions |
| US6516837B2 (en) | 2000-09-27 | 2003-02-11 | Honeywell International Inc. | Method of introducing refrigerants into refrigeration systems |
| US6962665B2 (en) * | 2000-12-08 | 2005-11-08 | E. I. Du Pont De Nemours And Company | Refrigerant compositions containing a compatibilizer |
| WO2002072159A1 (en) * | 2001-03-10 | 2002-09-19 | Turner Donald E | Sterilizer gas blend for use in sterilization applications |
| DE10203779A1 (de) | 2002-01-30 | 2003-07-31 | Solvay Fluor & Derivate | Gemische mit 1,1,1,3,3-Pentalfluorbutan und 1,1,1,2,3,3,3-Heptafluorpropan |
| JP2004110388A (ja) | 2002-09-18 | 2004-04-08 | Sharp Corp | タッチパネルを有する装置 |
| US7279451B2 (en) * | 2002-10-25 | 2007-10-09 | Honeywell International Inc. | Compositions containing fluorine substituted olefins |
| CA2503421C (en) | 2002-10-25 | 2015-01-06 | Rajiv R. Singh | Compositions containing fluorine substituted olefins |
| US20040089839A1 (en) | 2002-10-25 | 2004-05-13 | Honeywell International, Inc. | Fluorinated alkene refrigerant compositions |
| TWI645031B (zh) | 2005-06-24 | 2018-12-21 | 哈尼威爾國際公司 | 含有經氟取代之烯烴之組合物及其用途 |
| CN102264877B (zh) | 2008-12-23 | 2014-12-10 | 瑞弗化工有限公司 | 制冷润滑剂组合物 |
-
2003
- 2003-10-27 CA CA2503421A patent/CA2503421C/en not_active Expired - Lifetime
- 2003-10-27 WO PCT/US2003/033797 patent/WO2004037752A2/en not_active Ceased
- 2003-10-27 PT PT100111673T patent/PT2314654T/pt unknown
- 2003-10-27 KR KR1020057007169A patent/KR101319864B1/ko not_active Expired - Lifetime
- 2003-10-27 EP EP10011165.7A patent/EP2277968A3/de not_active Withdrawn
- 2003-10-27 ES ES10011164T patent/ES2728672T3/es not_active Expired - Lifetime
- 2003-10-27 TW TW092129751A patent/TW200418970A/zh unknown
- 2003-10-27 AU AU2003284352A patent/AU2003284352A1/en not_active Abandoned
- 2003-10-27 ES ES10011127.7T patent/ES2645635T3/es not_active Expired - Lifetime
- 2003-10-27 PT PT100111277T patent/PT2258819T/pt unknown
- 2003-10-27 DK DK10011131.9T patent/DK2258404T3/da active
- 2003-10-27 ES ES08020700.4T patent/ES2321796T5/es not_active Expired - Lifetime
- 2003-10-27 EP EP03776535A patent/EP1578883A4/de not_active Withdrawn
- 2003-10-27 TR TR2019/08011T patent/TR201908011T4/tr unknown
- 2003-10-27 EP EP10011131.9A patent/EP2258404B1/de not_active Expired - Lifetime
- 2003-10-27 JP JP2004547132A patent/JP2006503961A/ja not_active Withdrawn
- 2003-10-27 WO PCT/US2003/033874 patent/WO2004037913A2/en not_active Ceased
- 2003-10-27 CN CN201610413985.XA patent/CN106085362A/zh active Pending
- 2003-10-27 DE DE08020700T patent/DE08020700T1/de active Pending
- 2003-10-27 AT AT10006819T patent/ATE529491T1/de not_active IP Right Cessation
- 2003-10-27 ES ES10011131.9T patent/ES2645949T3/es not_active Expired - Lifetime
- 2003-10-27 KR KR1020127016685A patent/KR101331776B1/ko not_active Expired - Fee Related
- 2003-10-27 EP EP10011129.3A patent/EP2287282B1/de not_active Revoked
- 2003-10-27 EP EP10011164.0A patent/EP2277972B1/de not_active Revoked
- 2003-10-27 EP EP16204715.3A patent/EP3170880B1/de not_active Expired - Lifetime
- 2003-10-27 CN CN201610413983.0A patent/CN106085361A/zh active Pending
- 2003-10-27 KR KR1020127018763A patent/KR101322632B1/ko not_active Expired - Lifetime
- 2003-10-27 SG SG2009071473A patent/SG194236A1/en unknown
- 2003-10-27 BR BRPI0315633-8A patent/BRPI0315633B1/pt not_active IP Right Cessation
- 2003-10-27 ES ES10011167.3T patent/ES2601879T3/es not_active Expired - Lifetime
- 2003-10-27 BR BR0315633-8A patent/BR0315633A/pt active IP Right Grant
- 2003-10-27 KR KR1020117013139A patent/KR101235583B1/ko not_active Expired - Fee Related
- 2003-10-27 PT PT03777896T patent/PT1563032E/pt unknown
- 2003-10-27 TW TW092129750A patent/TWI291492B/zh not_active IP Right Cessation
- 2003-10-27 DK DK03777896.6T patent/DK1563032T3/da active
- 2003-10-27 US US10/694,273 patent/US7534366B2/en not_active Expired - Lifetime
- 2003-10-27 ES ES16204715T patent/ES2794405T3/es not_active Expired - Lifetime
- 2003-10-27 EP EP10011162.4A patent/EP2277971A3/de not_active Withdrawn
- 2003-10-27 HU HUE16204715A patent/HUE049351T2/hu unknown
- 2003-10-27 HU HUE10011167A patent/HUE030549T2/en unknown
- 2003-10-27 ES ES10011130.1T patent/ES2637087T3/es not_active Expired - Lifetime
- 2003-10-27 CN CN201110006890.3A patent/CN102140329B/zh not_active Expired - Lifetime
- 2003-10-27 US US10/694,079 patent/US6858571B2/en not_active Expired - Lifetime
- 2003-10-27 AT AT03777896T patent/ATE556124T1/de active
- 2003-10-27 EP EP09160592A patent/EP2098581A3/de not_active Withdrawn
- 2003-10-27 EP EP08020700.4A patent/EP2036943B2/de not_active Expired - Lifetime
- 2003-10-27 EP EP09177661A patent/EP2163591A3/de not_active Withdrawn
- 2003-10-27 EP EP03777896A patent/EP1563032B1/de not_active Revoked
- 2003-10-27 DK DK10011164.0T patent/DK2277972T3/da active
- 2003-10-27 DK DK08020700.4T patent/DK2036943T4/en active
- 2003-10-27 EP EP17183878.2A patent/EP3301127A1/de not_active Withdrawn
- 2003-10-27 EP EP10011168.1A patent/EP2277983A3/de not_active Withdrawn
- 2003-10-27 CN CN201611144326.7A patent/CN106634852A/zh active Pending
- 2003-10-27 EP EP10006819.6A patent/EP2228421B2/de not_active Expired - Lifetime
- 2003-10-27 DK DK10011167.3T patent/DK2314654T3/en active
- 2003-10-27 CN CN201611139232.0A patent/CN106833535A/zh active Pending
- 2003-10-27 EP EP10011130.1A patent/EP2258784B1/de not_active Expired - Lifetime
- 2003-10-27 CN CN201611042353.3A patent/CN106753251A/zh active Pending
- 2003-10-27 EP EP20100011161 patent/EP2277942A3/de not_active Withdrawn
- 2003-10-27 EP EP10011127.7A patent/EP2258819B1/de not_active Expired - Lifetime
- 2003-10-27 EP EP10011160.8A patent/EP2277602A3/de not_active Withdrawn
- 2003-10-27 CN CN201611042345.9A patent/CN106753250A/zh active Pending
- 2003-10-27 DK DK16204715.3T patent/DK3170880T3/da active
- 2003-10-27 EP EP10011166.5A patent/EP2277943A3/de not_active Withdrawn
- 2003-10-27 HU HUE10011164A patent/HUE043295T2/hu unknown
- 2003-10-27 ES ES03777896T patent/ES2382912T3/es not_active Expired - Lifetime
- 2003-10-27 PT PT10011164T patent/PT2277972T/pt unknown
- 2003-10-27 EP EP20100011163 patent/EP2314653A3/de not_active Withdrawn
- 2003-10-27 CN CNA2003801074623A patent/CN1732243A/zh active Pending
- 2003-10-27 AT AT08020700T patent/ATE516321T2/de active
- 2003-10-27 EP EP10011167.3A patent/EP2314654B1/de not_active Revoked
- 2003-10-27 DK DK10011130.1T patent/DK2258784T3/en active
- 2003-10-27 CN CN201610413880.4A patent/CN106147717A/zh active Pending
- 2003-10-27 SI SI200332614T patent/SI3170880T1/sl unknown
- 2003-10-27 JP JP2004547148A patent/JP4699758B2/ja not_active Expired - Lifetime
- 2003-10-27 AU AU2003286685A patent/AU2003286685C1/en not_active Expired
- 2003-10-27 PT PT162047153T patent/PT3170880T/pt unknown
- 2003-10-27 RU RU2005115867/04A patent/RU2395555C2/ru active
- 2003-10-27 MX MXPA05004292A patent/MXPA05004292A/es active IP Right Grant
- 2003-10-27 EP EP20100011128 patent/EP2314652A3/de not_active Withdrawn
- 2003-10-27 EP EP09177662A patent/EP2163592A3/de not_active Withdrawn
- 2003-10-27 SI SI200332594T patent/SI2277972T1/sl unknown
- 2003-10-27 ES ES10011129.3T patent/ES2615857T3/es not_active Expired - Lifetime
- 2003-10-27 CN CN201611139231.6A patent/CN106590536A/zh active Pending
-
2005
- 2005-04-21 IL IL168198A patent/IL168198A/en active IP Right Grant
- 2005-05-24 ZA ZA200504236A patent/ZA200504236B/en unknown
-
2009
- 2009-04-10 RU RU2009113568/05A patent/RU2009113568A/ru not_active Application Discontinuation
-
2010
- 2010-05-18 JP JP2010113902A patent/JP2010235950A/ja active Pending
- 2010-09-21 AU AU2010224356A patent/AU2010224356B2/en not_active Expired
- 2010-12-21 IL IL210137A patent/IL210137A/en active IP Right Grant
-
2013
- 2013-01-24 JP JP2013011382A patent/JP5886216B2/ja not_active Expired - Lifetime
-
2015
- 2015-02-06 JP JP2015022150A patent/JP6066431B2/ja not_active Expired - Lifetime
-
2016
- 2016-03-23 RU RU2016110718A patent/RU2016110718A/ru unknown
- 2016-08-04 JP JP2016153408A patent/JP2017031407A/ja not_active Withdrawn
- 2016-11-03 CY CY20161101122T patent/CY1118652T1/el unknown
-
2017
- 2017-01-26 JP JP2017012192A patent/JP6478336B2/ja not_active Expired - Lifetime
-
2018
- 2018-07-27 JP JP2018141231A patent/JP2018188659A/ja active Pending
-
2019
- 2019-06-12 CY CY20191100614T patent/CY1122370T1/el unknown
- 2019-09-30 JP JP2019178273A patent/JP2020015920A/ja active Pending
-
2020
- 2020-02-27 JP JP2020031459A patent/JP2020100835A/ja active Pending
- 2020-07-02 CY CY20201100610T patent/CY1123512T1/el unknown
-
2021
- 2021-06-23 JP JP2021103744A patent/JP2021152177A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE08020700T1 (de) | Zusammensetzungen mit fluorosubstituierten Olefinen | |
| DE60305446T2 (de) | Desazapurine und deren verwendung | |
| DE2922523C2 (de) | Aminothiazole und diese enthaltende Arzneimitte l | |
| DE69803376T2 (de) | Äthylenglykolester von monohydrobenzoporphyrinderivaten als photoaktive mittel | |
| DE19524515A1 (de) | Saccharid-Konjugate | |
| EP0509398B1 (de) | Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE199636T1 (de) | Benzoenaphthalinderivate, verfahren zu deren herstellung und ihre verwendung in pharmazie und kosmetik. | |
| LU83982A1 (de) | Platin-diamin-komplexe,ein verfahren zu ihrer herstellung,ein verfahren zur herstellung eines arzneimittels unter einsatz eines derartigen platin-diamin-komplexes fuer die behandlung von krebs sowie das dabei erhaltene arzneimittel | |
| DE4126662A1 (de) | Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel | |
| DE60026010T2 (de) | Substituierte stilbene mit gefässschädigender aktivität | |
| DE69432022T2 (de) | Polyazacycloalkane als doppelte chelatbildner | |
| DE2160946A1 (de) | Aminosäureamide disubstituierter Phenathylamine | |
| DE60032620T2 (de) | Antikrebsmittel | |
| RU2008149461A (ru) | Фосфоросодержащие соединения, в том числе сложные эфиры трифенилметилфосфоновой кислоты для лечения меланомы и других раковых заболеваний | |
| WO2000051602A1 (de) | Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas | |
| DE60000590T2 (de) | Nitroimidazolderivate als Empfindlichkeitsverstärker für Chemotherapie und Radiotherapie | |
| RU2012103889A (ru) | Фармацевтические композиции и терапевтические способы, в которых применяется комбинация комплексного соединения марганца и соединения в форме, не являющейся марганцевым комплексом | |
| DE2907349C2 (de) | Arzneimittel mit cytostatischer Wirksamkeit | |
| DE69318046T2 (de) | Antikrebsbenzaldehydverbindungen | |
| DE3218792A1 (de) | Isoprenylaminderivate und deren saeureadditionssalze | |
| EP0194571B1 (de) | Heterocyclische Disulfide, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten | |
| DE60132981T2 (de) | Duale moleküle enthaltend ein peroxydderivat,deren synthese und deren verwendung als heilmittel | |
| DE69907448T2 (de) | Pyrido[2,3-b]indolizinderivate und aza analoge: crf1 spezifische liganden | |
| DE2428409A1 (de) | Acylderivate von 5-mercaptopyridoxin und dessen disulfid | |
| CH645094A5 (de) | Hydrazon-verbindungen, verfahren zur herstellung derselben und antibakterielle mittel mit einem gehalt derselben. |